BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235-240. [PMID: 12759473 DOI: 10.1148/radiol.2281020718] [Cited by in Crossref: 701] [Cited by in F6Publishing: 578] [Article Influence: 38.9] [Reference Citation Analysis]
Number Citing Articles
1 Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK. Percutaneous Radiofrequency Ablation Therapy of Hepatocellular Carcinoma Using Multitined Expandable Electrodes: Comparison of Subcapsular and Nonsubcapsular Tumors. American Journal of Roentgenology 2006;186:S269-74. [DOI: 10.2214/ajr.04.1346] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Rim CH, Kim HJ, Seong J. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Radiother Oncol. 2019;131:135-144. [PMID: 30773180 DOI: 10.1016/j.radonc.2018.12.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 14.7] [Reference Citation Analysis]
3 Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Tina Shih YC. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health 2019;22:284-92. [PMID: 30832966 DOI: 10.1016/j.jval.2018.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007;72 Suppl 1:98-103. [PMID: 18087189 DOI: 10.1159/000111714] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
5 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 90.0] [Reference Citation Analysis]
6 Joung KW, Choi SS, Jang DM, Kong YG, Lee HM, Shim JH, Won HJ, Shin YM, Kim PN, Song MH. Comparative Effects of Dexmedetomidine and Propofol on US-Guided Radiofrequency Ablation of Hepatic Neoplasm Under Monitored Anesthesia Care: A Randomized Controlled Study. Medicine (Baltimore) 2015;94:e1349. [PMID: 26266387 DOI: 10.1097/MD.0000000000001349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hirooka M, Hiraoka A, Ochi H, Kisaka Y, Joko K, Michitaka K, Hiasa Y. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma. AJR Am J Roentgenol 2018;210:891-8. [PMID: 29412017 DOI: 10.2214/AJR.17.18177] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
8 Nishikawa H, Kimura T, Kita R, Osaki Y. Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia. 2013;29:558-568. [PMID: 23937321 DOI: 10.3109/02656736.2013.821528] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
9 Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, Kim WT, Byun JH. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352-361. [PMID: 18008352 DOI: 10.1002/cncr.23185] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 6.4] [Reference Citation Analysis]
10 Huo TI, Huang YH, Wu JC. Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. J Chin Med Assoc 2005;68:155-9. [PMID: 15850062 DOI: 10.1016/S1726-4901(09)70239-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Cheung W, Kavnoudias H, Roberts S, Szkandera B, Kemp W, Thomson KR. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol Cancer Res Treat. 2013;12:233-241. [PMID: 23369152 DOI: 10.7785/tcrt.2012.500317] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 10.9] [Reference Citation Analysis]
12 Jiang YQ, Wang ZX, Deng YN, Yang Y, Wang GY, Chen GH. Efficacy of Hepatic Resection vs. Radiofrequency Ablation for Patients With Very-Early-Stage or Early-Stage Hepatocellular Carcinoma: A Population-Based Study With Stratification by Age and Tumor Size. Front Oncol. 2019;9:113. [PMID: 30863723 DOI: 10.3389/fonc.2019.00113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
13 Viganò L, Laurenzi A, Solbiati L, Procopio F, Cherqui D, Torzilli G. Open Liver Resection, Laparoscopic Liver Resection, and Percutaneous Thermal Ablation for Patients with Solitary Small Hepatocellular Carcinoma (≤30 mm): Review of the Literature and Proposal for a Therapeutic Strategy. Dig Surg 2018;35:359-71. [PMID: 29890512 DOI: 10.1159/000489836] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
14 Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J Hepatol. 2005;43:377-380. [PMID: 16005537 DOI: 10.1016/j.jhep.2005.06.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
15 Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Am J Clin Oncol. 2008;31:311-316. [PMID: 18845987 DOI: 10.1097/coc.0b013e31815e4539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sung YM, Choi D, Lim HK, Lee WJ, Kim SH, Kim MJ, Paik SW, Yoo BC, Koh KC, Lee JH, Choi MS. Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea. Korean J Radiol 2006;7:187-92. [PMID: 16969048 DOI: 10.3348/kjr.2006.7.3.187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
17 Maruyama H, Takahashi M, Ishibashi H, Okugawa H, Okabe S, Yoshikawa M, Yokosuka O. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int 2009;29:708-14. [PMID: 18803588 DOI: 10.1111/j.1478-3231.2008.01875.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
18 Imai K, Beppu T, Chikamoto A, Mima K, Okabe H, Hayashi H, Nitta H, Ishiko T, Baba H. Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy: Salvage for local recurrence of HCC. Hepatol Res 2014;44:E335-45. [DOI: 10.1111/hepr.12313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
19 Putzer D, Schullian P, Braunwarth E, Fodor M, Primavesi F, Cardini B, Resch T, Oberhuber R, Maglione M, Margreiter C, Schneeberger S, Stättner S, Öfner-Velano D, Jaschke W, Bale RJ. Integrating interventional oncology in the treatment of liver tumors. Eur Surg 2018;50:117-24. [PMID: 29875800 DOI: 10.1007/s10353-018-0521-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
20 Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12:1098-104. [PMID: 16534852 DOI: 10.3748/wjg.v12.i7.1098] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
21 Rempp H, Boss A, Helmberger T, Pereira P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging. 2011;36:635-647. [PMID: 21562884 DOI: 10.1007/s00261-011-9749-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
22 Mizuki A, Tatemichi M, Tsukada N, Nagamatsu R, Kawaguchi M, Itoshima T, Maruyama S, Satou A, Imari Y, Kawatoko T. Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study. Oncol Lett. 2010;1:855-859. [PMID: 22966394 DOI: 10.3892/ol_00000151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
23 Nguyen MH, Keeffe EB. General management. Best Practice & Research Clinical Gastroenterology 2005;19:161-74. [DOI: 10.1016/j.bpg.2004.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
24 Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41-52. [PMID: 15777889 DOI: 10.1016/j.suronc.2005.01.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
25 Tian G, Yang S, Yuan J, Threapleton D, Zhao Q, Chen F, Cao H, Jiang T, Li L. Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis. BMJ Open. 2018;8:e021269. [PMID: 30341113 DOI: 10.1136/bmjopen-2017-021269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
26 Yuan Z, Wang Y, Hu C, Gao W, Zheng J, Li W. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival. Technol Cancer Res Treat 2018;17:1533033818801362. [PMID: 30244651 DOI: 10.1177/1533033818801362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Graf D, Vallböhmer D, Knoefel WT, Kröpil P, Antoch G, Sagir A, Häussinger D. Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med. 2014;25:430-437. [PMID: 24666568 DOI: 10.1016/j.ejim.2014.03.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
28 Covey AM, Hussain SM. Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings. American Journal of Roentgenology 2017;209:67-76. [DOI: 10.2214/ajr.17.17799] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
29 Hänsler J, Frieser M, Tietz V, Uhlke D, Wissniowski T, Bernatik T, Hothorn T, Hahn EG, Strobel D. Percutaneous Radiofrequency Ablation of Liver Tumors Using Multiple Saline-Perfused Electrodes. Journal of Vascular and Interventional Radiology 2007;18:405-10. [DOI: 10.1016/j.jvir.2006.12.729] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
30 Frieser M, Haensler J, Schaber S, Peters A, Mohelsky E, Bernatik T, Hahn E, Strobel D. Radiofrequency Ablation of Liver Tumors: How to Enlarge the Necrotic Zones? Eur Surg Res 2004;36:357-61. [DOI: 10.1159/000081644] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Maruyama H, Takahashi M, Shimada T, Sekimoto T, Kamesaki H, Kanai F, Yokosuka O. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation. AJR Am J Roentgenol. 2013;200:570-577. [PMID: 23436846 DOI: 10.2214/ajr.12.8999] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
32 Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. Journal of Gastroenterology and Hepatology 2009;24:223-7. [DOI: 10.1111/j.1440-1746.2008.05596.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
33 Chen W, Fernandes ML, Lin C, Lin S. Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program: Delay in RFA for HCC Impacts Survival. J Surg Oncol 2011;103:133-9. [DOI: 10.1002/jso.21797] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
34 Kairaluoma V, Karjalainen M, Pohjanen VM, Saarnio J, Niemelä J, Huhta H, Helminen O. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 years. Minerva Surg 2021;76:252-63. [PMID: 33890436 DOI: 10.23736/S2724-5691.21.08426-1] [Reference Citation Analysis]
35 Liu B, Zhou L, Huang G, Zhong Z, Jiang C, Shan Q, Xu M, Kuang M, Xie X. First Experience of Ultrasound-guided Percutaneous Ablation for Recurrent Hepatoblastoma after Liver Resection in Children. Sci Rep 2015;5:16805. [PMID: 26578035 DOI: 10.1038/srep16805] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
36 Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Korean J Intern Med. 2016;31:242-252. [PMID: 26874512 DOI: 10.3904/kjim.2015.112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
37 Yu HC, Cheng JS, Lai KH, Lin CP, Lo GH, Lin CK, Hsu PI, Chan HH, Lo CC, Tsai WL, Chen WC. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005;11:1439-44. [PMID: 15770718 DOI: 10.3748/wjg.v11.i10.1439] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
38 Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol. 2005;11:7391-7400. [PMID: 16437707 DOI: 10.3748/wjg.v11.i47.7391] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 91] [Article Influence: 2.4] [Reference Citation Analysis]
39 Shen A, Zhang H, Tang C, Chen Y, Wang Y, Zhang C, Wu Z. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. J Gastroenterol Hepatol. 2013;28:793-800. [PMID: 23432154 DOI: 10.1111/jgh.12162] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
40 Ippolito D, Pecorelli A, Querques G, Drago SG, Maino C, Franzesi CT, Hatzidakis A, Sironi S. Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up. Acad Radiol 2019;26:1675-85. [PMID: 30852079 DOI: 10.1016/j.acra.2019.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Seror O, N′kontchou G, Haddar D, Dordea M, Ajavon Y, Ganne N, Trinchet JC, Beaugrand M, Sellier N. Large Infiltrative Hepatocellular Carcinomas: Treatment with Percutaneous Intraarterial Ethanol Injection Alone or in Combination with Conventional Percutaneous Ethanol Injection. Radiology 2005;234:299-309. [DOI: 10.1148/radiol.2341031008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
42 Zhao J, Zhang H, Wei L, Xie S, Suo Z. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget 2017;8:15101-13. [PMID: 27835871 DOI: 10.18632/oncotarget.13145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
43 Pacella CM, Francica G, Di Lascio FM, Arienti V, Antico E, Caspani B, Magnolfi F, Megna AS, Pretolani S, Regine R. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J Clin Oncol. 2009;27:2615-2621. [PMID: 19332729 DOI: 10.1200/jco.2008.19.0082] [Cited by in Crossref: 86] [Cited by in F6Publishing: 22] [Article Influence: 7.2] [Reference Citation Analysis]
44 Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 2006;25:3848-3856. [PMID: 16799626 DOI: 10.1038/sj.onc.1209548] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 7.3] [Reference Citation Analysis]
45 Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C, Tasselli S, Iacono C. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg. 2007;11:143-149. [PMID: 17390163 DOI: 10.1007/s11605-006-0082-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
46 Di Vece F, Tombesi P, Ermili F, Maraldi C, Sartori S. Coagulation Areas Produced by Cool-Tip Radiofrequency Ablation and Microwave Ablation Using a Device to Decrease Back-Heating Effects: A Prospective Pilot Study. Cardiovasc Intervent Radiol. [DOI: 10.1007/s00270-013-0733-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
47 Mulcahy MF. Management of hepatocellular cancer. Curr Treat Options Oncol. 2005;6:423-435. [PMID: 16107245 DOI: 10.1007/s11864-005-0045-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
48 Kimura K, Nakamura T, Ono T, Azami Y, Suzuki M, Wada H, Takayama K, Endo H, Takeyama T, Hirose K, Takai Y, Kikuchi Y. Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm. Hepatol Res 2017;47:1368-74. [PMID: 28198132 DOI: 10.1111/hepr.12874] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
49 Yamane B, Weber S. Liver-Directed Treatment Modalities for Primary and Secondary Hepatic Tumors. Surgical Clinics of North America 2009;89:97-113. [DOI: 10.1016/j.suc.2008.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
50 Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, Kondo F, Saisho H. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol. 2005;43:458-464. [PMID: 16005538 DOI: 10.1016/j.jhep.2005.03.033] [Cited by in Crossref: 129] [Cited by in F6Publishing: 106] [Article Influence: 8.1] [Reference Citation Analysis]
51 Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas. World J Gastrointest Surg. 2010;2:137-142. [PMID: 21160862 DOI: 10.4240/wjgs.v2.i4.137] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
52 Lencioni R, Crocetti L. A Critical Appraisal of the Literature on Local Ablative Therapies for Hepatocellular Carcinoma. Clinics in Liver Disease 2005;9:301-14. [DOI: 10.1016/j.cld.2004.12.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
53 Himoto T, Kurokohchi K, Watanabe S, Masaki T. Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma. Hepat Mon. 2012;12:e5945. [PMID: 23162600 DOI: 10.5812/hepatmon.5945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
54 de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. Journal of Hepatology 2012;56:S75-87. [DOI: 10.1016/s0168-8278(12)60009-9] [Cited by in Crossref: 363] [Cited by in F6Publishing: 192] [Article Influence: 40.3] [Reference Citation Analysis]
55 McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005;17:497-503. [PMID: 15827439 DOI: 10.1097/00042737-200505000-00005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
56 Blum HE. Treatment of hepatocellular carcinoma. Best Practice & Research Clinical Gastroenterology 2005;19:129-45. [DOI: 10.1016/j.bpg.2004.11.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
57 Guarneri A, Franco P, Romagnoli R, Trino E, Mirabella S, Molinaro L, Rizza G, Filippi AR, Carucci P, Salizzoni M, Ricardi U. Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma. Radiol med 2016;121:873-81. [DOI: 10.1007/s11547-016-0670-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
58 Requarth J. Image-Guided Palliative Care Procedures. Surgical Clinics of North America 2011;91:367-402. [DOI: 10.1016/j.suc.2010.12.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
59 Baum RA, Baum S. Interventional radiology: a half century of innovation. Radiology 2014;273:S75-91. [PMID: 25340439 DOI: 10.1148/radiol.14140534] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
60 Kotoh K, Enjoji M, Arimura E, Morizono S, Kohjima M, Sakai H, Nakamuta M. Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma. World J Gastroenterol 2005;11:6828-32. [PMID: 16425391 DOI: 10.3748/wjg.v11.i43.6828] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
61 Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts. Cardiovasc Intervent Radiol. 2006;29:778-784. [PMID: 16779690 DOI: 10.1007/s00270-005-0063-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
62 Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008;6:1418-1424. [PMID: 18848905 DOI: 10.1016/j.cgh.2008.08.005] [Cited by in Crossref: 139] [Cited by in F6Publishing: 114] [Article Influence: 10.7] [Reference Citation Analysis]
63 Cai D, Li Y, Jiang Y, Wang H, Wang X, Song B. The role of contrast-enhanced ultrasound in the diagnosis of hepatic alveolar echinococcosis. Medicine (Baltimore) 2019;98:e14325. [PMID: 30702614 DOI: 10.1097/MD.0000000000014325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
64 Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Takaki H, Nakatsuka A. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization. Aliment Pharmacol Ther. 2008;27:1253-1260. [PMID: 18221404 DOI: 10.1111/j.1365-2036.2008.03627.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
65 Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20:10174-10182. [PMID: 25110446 DOI: 10.3748/wjg.v20.i29.10174] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
66 Nicolau C, Vilana R, Bianchi L, Brú C. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol Suppl 2007;17:80-8. [DOI: 10.1007/s10406-007-0232-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
67 Walzer N, Kulik LM. Hepatocellular carcinoma: latest developments. Curr Opin Gastroenterol 2008;24:312-9. [PMID: 18408459 DOI: 10.1097/MOG.0b013e3282fafef3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
68 Lopez PM, Patel P, Uva P, Villanueva A, Llovet JM. Current management of liver cancer. European Journal of Cancer Supplements 2007;5:444-6. [DOI: 10.1016/s1359-6349(07)70093-9] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
69 Wakai T, Shirai Y, Suda T, Yokoyama N, Sakata J, Cruz PV, Kawai H, Matsuda Y, Watanabe M, Aoyagi Y. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm. World J Gastroenterol. 2006;12:546-552. [PMID: 16489666 DOI: 10.3748/wjg.v12.i4.546] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
70 Lencioni R, Pina CD, Bruix J, Majno P, Grazioli L, Morana G, Filippone A, Laghi A, Bartolozzi C. Clinical Management of Hepatic Malignancies: Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Contrast-Enhanced Spiral Computed Tomography. Dig Dis Sci 2005;50:533-7. [DOI: 10.1007/s10620-005-2469-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
71 Kaibori M, Matsui Y, Kwon A, Tokoro T, Kamiyama Y. Prognosis of Hepatocellular Carcinoma after Hepatectomy in Patients with Renal Dysfunction. World J Surg 2005;29:375-81. [DOI: 10.1007/s00268-004-7515-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
72 El-serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterology 2008;134:1752-63. [DOI: 10.1053/j.gastro.2008.02.090] [Cited by in Crossref: 690] [Cited by in F6Publishing: 618] [Article Influence: 53.1] [Reference Citation Analysis]
73 Miyamoto N, Hiramatsu K, Tsuchiya K, Sato Y. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography. J Clin Ultrasound. 2010;38:339-345. [PMID: 20572066 DOI: 10.1002/jcu.20720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
74 Latteri F, Sandonato L, Di Marco V, Parisi P, Cabibbo G, Lombardo G, Galia M, Midiri M, Latteri MA, Craxì A. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2008;40:684-689. [PMID: 18294940 DOI: 10.1016/j.dld.2007.12.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
75 Liapi E, Geschwind JF. Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablation. Ann Surg Oncol 2011;18:1527-8. [PMID: 21431403 DOI: 10.1245/s10434-011-1679-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
76 Luo W, Zhang Y, He G, Yu M, Zheng M, Liu L, Zhou X. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis. World J Surg Oncol 2017;15:126. [PMID: 28693505 DOI: 10.1186/s12957-017-1196-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
77 Lee JM, Han JK, Kim SH, Lee JY, Choi SH, Choi BI. Hepatic bipolar radiofrequency ablation using perfused-cooled electrodes: a comparative study in the ex vivo bovine liver. BJR 2004;77:944-9. [DOI: 10.1259/bjr/67069976] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
78 Forner A, Ayuso C, Varela M, Rimola J, Hessheimer AJ, de Lope CR, Reig M, Bianchi L, Llovet JM, Bruix J. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer. 2009;115:616-623. [PMID: 19117042 DOI: 10.1002/cncr.24050] [Cited by in Crossref: 303] [Cited by in F6Publishing: 274] [Article Influence: 25.3] [Reference Citation Analysis]
79 Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005;29:1364-1373. [PMID: 16240062 DOI: 10.1007/s00268-005-7829-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
80 Ng KK, Poon RT, Lo C, Yuen J, Tso WK, Fan S. Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:183-91. [DOI: 10.1007/s11605-007-0276-y] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 8.2] [Reference Citation Analysis]
81 Bouza C, López-Cuadrado T, Alcázar R, Saz-Parkinson Z, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol. 2009;9:31. [PMID: 19432967 DOI: 10.1186/1471-230x-9-31] [Cited by in Crossref: 101] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
82 Su YY, Li CC, Lin YJ, Hsu C. Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives. Semin Liver Dis 2021;41:263-76. [PMID: 34130338 DOI: 10.1055/s-0041-1730949] [Reference Citation Analysis]
83 Xu RH, Gao W, Wang C, Guo DK, Tang L, Zhang H, Wang CJ. Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis. Eur J Med Res 2014;19:39. [PMID: 25141776 DOI: 10.1186/2047-783X-19-39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
84 Bimonte S, Barbieri A, Palaia R, Leongito M, Albino V, Piccirillo M, Arra C, Izzo F. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. Infect Agent Cancer 2015;10:9. [PMID: 25755676 DOI: 10.1186/s13027-015-0004-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
85 Schlachterman A, Craft WW, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol. 2015;21:8478-8491. [PMID: 26229392 DOI: 10.3748/wjg.v21.i28.8478] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 83] [Article Influence: 18.8] [Reference Citation Analysis]
86 Schullian P, Johnston EW, Putzer D, Eberle G, Laimer G, Bale R. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.Sci Rep. 2020;10:1618. [PMID: 32005871 DOI: 10.1038/s41598-020-58383-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
87 Kim TH, Koh YH, Kim BH, Kim MJ, Lee JH, Park B, Park J. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial. Journal of Hepatology 2021;74:603-12. [DOI: 10.1016/j.jhep.2020.09.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
88 Pleguezuelo M, Germani G, Marelli L, Xiruochakis E, Misseri M, Manousou P, Arvaniti V, Burroughs AK. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;2:761-84. [DOI: 10.1586/17474124.2.6.761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
89 Kirikoshi H, Yoneda M, Mawatari H, Fujita K, Imajo K, Kato S, Suzuki K, Kobayashi N, Kubota K, Maeda S. Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization? World J Gastroenterol. 2012;18:1933-1939. [PMID: 22563174 DOI: 10.3748/wjg.v18.i16.1933] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
90 Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 2012;4:19-37. [PMID: 24367230 DOI: 10.2147/hmer.s16316] [Cited by in Crossref: 39] [Cited by in F6Publishing: 123] [Article Influence: 4.3] [Reference Citation Analysis]
91 Park SH, Cho YK, Ahn YS, Park YO, Kim JK, Chung JW. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors. Korean J Radiol 2007;8:111-9. [PMID: 17420628 DOI: 10.3348/kjr.2007.8.2.111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
92 European Association For The Study Of The Liver. European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943. [PMID: 22424438 DOI: 10.1016/j.jhep.2011.12.001] [Cited by in Crossref: 3642] [Cited by in F6Publishing: 3343] [Article Influence: 404.7] [Reference Citation Analysis]
93 Niemeyer DJ, Simo KA, Iannitti DA, McKillop IH. Ablation therapy for hepatocellular carcinoma: past, present and future perspectives. Hepat Oncol 2014;1:67-79. [PMID: 30190942 DOI: 10.2217/hep.13.8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
94 Morishita A, Sakamoto T, Kobara H, Tadokoro T, Ohura K, Fujita K, Tani J, Miyoshi H, Yoneyama H, Himoto T, Masaki T. Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver. Mol Clin Oncol 2016;4:183-6. [PMID: 26893857 DOI: 10.3892/mco.2015.680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Becker G, Allgaier HP, Olschewski M, Zähringer A, Blum HE. Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study. Hepatology. 2007;45:9-15. [PMID: 17187405 DOI: 10.1002/hep.21468] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.4] [Reference Citation Analysis]
96 Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Chiba T, Kanai F, Okabe S, Yoshikawa M, Yokosuka O. Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan. Hepatol Int 2013;7:1030-9. [DOI: 10.1007/s12072-013-9470-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
97 Habibi M, Kmieciak M, Graham L, Morales JK, Bear HD, Manjili MH. Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis. Breast Cancer Res Treat 2009;114:423-31. [PMID: 18425677 DOI: 10.1007/s10549-008-0024-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
98 Geschwind J, Liapi E. Is radiofrequency ablation an effective long-term treatment for early-stage hepatocellular carcinoma? Nat Rev Gastroenterol Hepatol 2005;2:302-3. [DOI: 10.1038/ncpgasthep0210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?: . European Journal of Gastroenterology & Hepatology 2008;20:196-201. [DOI: 10.1097/meg.0b013e3282f1cc4a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
100 Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. [PMID: 25444471 DOI: 10.1016/j.soc.2014.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
101 Volk ML, Marrero JA. Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep. 2008;10:60-66. [PMID: 18417044 DOI: 10.1007/s11894-008-0010-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
102 Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120:194-202. [PMID: 17349437 DOI: 10.1016/j.amjmed.2006.11.020] [Cited by in Crossref: 107] [Cited by in F6Publishing: 90] [Article Influence: 7.6] [Reference Citation Analysis]
103 Seror O, N'Kontchou G, Nault JC, Rabahi Y, Nahon P, Ganne-Carrié N, Grando V, Zentar N, Beaugrand M, Trinchet JC, Diallo A, Sellier N. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. Radiology 2016;280:611-21. [PMID: 27010381 DOI: 10.1148/radiol.2016150743] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
104 Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Westerlund P, Henninger B, Bale R. Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study. Int J Hyperthermia 2020;37:564-72. [PMID: 32484004 DOI: 10.1080/02656736.2020.1766705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
105 Paulet E, Aubé C, Pessaux P, Lebigot J, Lhermitte E, Oberti F, Ponthieux A, Calès P, Ridereau-Zins C, Pereira PL. Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc Intervent Radiol 2008;31:107-15. [PMID: 17968620 DOI: 10.1007/s00270-007-9208-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
106 Rougier P, Mitry E, Barbare JC, Taieb J. Hepatocellular carcinoma (HCC): an update. Semin Oncol. 2007;34:S12-S20. [PMID: 17449346 DOI: 10.1053/j.seminoncol.2007.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
107 Willatt JM, Francis IR, Novelli PM, Vellody R, Pandya A, Krishnamurthy VN. Interventional therapies for hepatocellular carcinoma. Cancer Imaging 2012;12:79-88. [PMID: 22487698 DOI: 10.1102/1470-7330.2012.0011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
108 Bailey CW, Sydnor MK Jr. Current State of Tumor Ablation Therapies. Dig Dis Sci 2019;64:951-8. [PMID: 30859403 DOI: 10.1007/s10620-019-05514-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
109 Cho YB, Lee KU, Suh KS, Kim YJ, Yoon JH, Lee HS, Hahn S, Park BJ. Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching. J Gastroenterol Hepatol. 2007;22:1643-1649. [PMID: 17845692 DOI: 10.1111/j.1440-1746.2007.04902.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
110 Lin SM. Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer 2013;2:73-83. [PMID: 24159599 DOI: 10.1159/000343843] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
111 Takami Y, Ryu T, Wada Y, Saitsu H. Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases. J Hepatobiliary Pancreat Sci 2013;20:332-41. [PMID: 22710886 DOI: 10.1007/s00534-012-0527-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
112 Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. Aliment Pharmacol Ther. 2006;23:1535-1547. [PMID: 16696801 DOI: 10.1111/j.1365-2036.2006.02932.x] [Cited by in Crossref: 250] [Cited by in F6Publishing: 216] [Article Influence: 16.7] [Reference Citation Analysis]
113 Cua IH, Lin CC, Lin CJ, Chen WT, Hsu CW, Chen YC, Wong SN, Lin SM. Treatment of hepatocellular carcinoma using internally cooled electrodes. A prospective comparison of modified automated vs. manual pulsed radiofrequency algorithms. Oncology 2007;72 Suppl 1:76-82. [PMID: 18087186 DOI: 10.1159/000111711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
114 Bangard C, Rösgen S, Wahba R, Wiemker R, Hellmich M, Reiter H, Fischer JH, Stippel DL, Lackner KJ. Large-volume multi-tined expandable RF ablation in pig livers: comparison of 2D and volumetric measurements of the ablation zone. Eur Radiol 2010;20:1073-8. [PMID: 19915850 DOI: 10.1007/s00330-009-1639-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
115 Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Sakamoto A, Henmi S, Matsuda F, Eso Y, Ishikawa T, Saito S. Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol. 2011;46:1418-1426. [PMID: 21845378 DOI: 10.1007/s00535-011-0452-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
116 Yeh JH, Hung CH, Wang JH, Chen CH, Kee KM, Kuo CM, Yen YH, Cheng YF, Chen YY, Hsu HC, Lu SN. Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment. PLoS One 2015;10:e0144893. [PMID: 26661388 DOI: 10.1371/journal.pone.0144893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
117 Olsen SK, Brown RS, Siegel AB. Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. Therap Adv Gastroenterol. 2010;3:55-66. [PMID: 21180590 DOI: 10.1177/1756283x09346669] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
118 Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK. Planning Sonography to Assess the Feasibility of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas. American Journal of Roentgenology 2008;190:1324-30. [DOI: 10.2214/ajr.07.2970] [Cited by in Crossref: 72] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
119 Li Z, Zhang K, Lin S, Mi D, Cao N, Wen Z, Li Z. Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis. International Journal of Hyperthermia 2017;33:237-46. [DOI: 10.1080/02656736.2016.1237681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
120 Galandi D, Antes G, Galandi D. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd003046.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
121 Miyake T, Sato S, Okamoto E, Ishine J, Oshima N, Azumi T, Mishiro T, Furuta K, Ishihara S, Adachi K, Amano Y, Kinoshita Y. Ferucarbotran expands area treated by radiofrequency ablation in rabbit livers. Journal of Gastroenterology and Hepatology 2008;23:e270-4. [DOI: 10.1111/j.1440-1746.2007.05035.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
122 Gillams AR. Should hepatocellular carcinoma be ablated or resected? Nat Clin Pract Gastroenterol Hepatol 2007;4:586-7. [PMID: 17925802 DOI: 10.1038/ncpgasthep0962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, Zhou XD, Wang JR. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol. 2007;33:1736-1749. [PMID: 17629608 DOI: 10.1016/j.ultrasmedbio.2007.05.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
124 Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, Tsuchihashi T, Saigenji K. Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin. American Journal of Roentgenology 2007;188:480-8. [DOI: 10.2214/ajr.05.2079] [Cited by in Crossref: 242] [Cited by in F6Publishing: 89] [Article Influence: 17.3] [Reference Citation Analysis]
125 Forner A, Ayuso C, Isabel Real M, Sastre J, Robles R, Sangro B, Varela M, de la Mata M, Buti M, Martí-Bonmatí L, Bru C, Tabernero J, Llovet JM, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma]. Med Clin (Barc) 2009;132:272-87. [PMID: 19248879 DOI: 10.1016/j.medcli.2008.11.024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
126 Surveillance group. ; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc. 2018;117:381-403. [PMID: 29074347 DOI: 10.1016/j.jfma.2017.09.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
127 Abitabile P, Hartl U, Lange J, Maurer CA. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol. 2007;33:67-71. [PMID: 17174059 DOI: 10.1016/j.ejso.2006.10.040] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 6.4] [Reference Citation Analysis]
128 Arii S, Sata M, Sakamoto M, Shimada M, Kumada T, Shiina S, Yamashita T, Kokudo N, Tanaka M, Takayama T, Kudo M. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res. 2010;40:667-685. [PMID: 20633193 DOI: 10.1111/j.1872-034x.2010.00673.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 45] [Article Influence: 12.9] [Reference Citation Analysis]
129 Chang NK, Shin SS, Kim JW, Kim HJ, Jeong YY, Heo SH, Kim JK, Kang HK. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Korean J Radiol 2012;13 Suppl 1:S104-11. [PMID: 22563280 DOI: 10.3348/kjr.2012.13.S1.S104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
130 Chan ACY, Poon RTP, Ng KKC, Lo CM, Fan ST, Wong J. Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening. Annals of Surgery 2008;247:666-73. [DOI: 10.1097/sla.0b013e31816a747a] [Cited by in Crossref: 68] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
131 Martins A, Cortez-Pinto H, Marques-Vidal P, Mendes N, Silva S, Fatela N, Glória H, Marinho R, Távora I, Ramalho F. Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int. 2006;26:680-687. [PMID: 16842324 DOI: 10.1111/j.1478-3231.2006.001285.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
132 Taieb J, Barbare J, Rougier P. Medical treatments for hepatocellular carcinoma (HCC): what’s next? Annals of Oncology 2006;17:x308-14. [DOI: 10.1093/annonc/mdl279] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
133 Korean Liver Cancer Study Group and National Cancer Center, Korea. [Practice guidelines for management of hepatocellular carcinoma 2009]. Korean J Hepatol. 2009;15:391-423. [PMID: 19783891 DOI: 10.3350/kjhep.2009.15.3.391] [Cited by in Crossref: 182] [Cited by in F6Publishing: 177] [Article Influence: 16.5] [Reference Citation Analysis]
134 McWilliams JP, Yamamoto S, Raman SS, Loh CT, Lee EW, Liu DM, Kee ST. Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol. 2010;21:S204-S213. [PMID: 20656230 DOI: 10.1016/j.jvir.2009.11.025] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
135 Seinstra BA, van Delden OM, van Erpecum KJ, van Hillegersberg R, Mali WP, van den Bosch MA. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? Insights Imaging. 2010;1:167-181. [PMID: 23100194 DOI: 10.1007/s13244-010-0027-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
136 Becker G, Schmitt-Graeff A, Ertelt V, Blum HE, Allgaier HP. CD117 (c-kit) expression in human hepatocellular carcinoma. Clin Oncol (R Coll Radiol). 2007;19:204-208. [PMID: 17359908 DOI: 10.1016/j.clon.2006.12.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
137 Lencioni R, Crocetti L, Pina MCD, Cioni D. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009;34:547-56. [DOI: 10.1007/s00261-008-9479-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
138 Lencioni R, Crocetti L, De Simone P, Filipponi F. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects. Transpl Int. 2010;23:698-703. [PMID: 20492618 DOI: 10.1111/j.1432-2277.2010.01109.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
139 Lencioni R, Cioni D, Lera J, Rocchi E, Della Pina C, Crocetti L. Radiofrequency Ablation: Principles and Techniques. In: Lencioni R, Cioni D, Bartolozzi C, editors. Focal Liver Lesions. Berlin: Springer Berlin Heidelberg; 2005. pp. 307-15. [DOI: 10.1007/3-540-26354-3_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
140 Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50:683-691. [PMID: 9250266 DOI: 10.1097/md.0000000000003185] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
141 Mazzanti R, Gramantieri L, Bolondi L. Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med. 2008;29:130-143. [PMID: 18061252 DOI: 10.1016/j.mam.2007.09.008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
142 Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ookawa A, Hashii H, Kanemoto A, Moritake T, Tohno E, Tsuboi K, Sakae T, Sakurai H. Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys. 2011;81:1039-1045. [PMID: 20888707 DOI: 10.1016/j.ijrobp.2010.07.015] [Cited by in Crossref: 102] [Cited by in F6Publishing: 77] [Article Influence: 9.3] [Reference Citation Analysis]
143 Guimaraes M, Uflacker R. Locoregional therapy for hepatocellular carcinoma. Clin Liver Dis 2011;15:395-421, vii-x. [PMID: 21689621 DOI: 10.1016/j.cld.2011.03.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
144 Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J. Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. J Hepatocell Carcinoma 2021;8:625-44. [PMID: 34189133 DOI: 10.2147/JHC.S298709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Lee JM, Han JK, Kim SH, Choi SH, An SK, Han CJ, Choi BI. Bipolar Radiofrequency Ablation Using Wet-Cooled Electrodes: An In Vitro Experimental Study in Bovine Liver. American Journal of Roentgenology 2005;184:391-7. [DOI: 10.2214/ajr.184.2.01840391] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
146 Wong J, Lee K, Lee P, Ho S, Yu S, Ng W, Cheung Y, Tsang Y, Ling E, Lai P. Radiofrequency Ablation for 110 Malignant Liver Tumours: Preliminary Results on Percutaneous and Surgical Approaches. Asian Journal of Surgery 2009;32:13-20. [DOI: 10.1016/s1015-9584(09)60003-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
147 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet 2003;362:1907-17. [DOI: 10.1016/s0140-6736(03)14964-1] [Cited by in Crossref: 3076] [Cited by in F6Publishing: 1247] [Article Influence: 170.9] [Reference Citation Analysis]
148 Shiina S, Sato K, Tateishi R, Shimizu M, Ohama H, Hatanaka T, Takawa M, Nagamatsu H, Imai Y. Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery. Can J Gastroenterol Hepatol 2018;2018:4756147. [PMID: 29974040 DOI: 10.1155/2018/4756147] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
149 Higgins MC, Soulen MC. Multimodality Approaches for Control of Hepatocellular Carcinoma. Techniques in Vascular and Interventional Radiology 2007;10:64-6. [DOI: 10.1053/j.tvir.2007.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
150 Abrishami A, Nasseri-moghaddam S, Eghtesad B, Sherman M, Abrishami A. Surgical resection for hepatocellular carcinoma. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd006935] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
151 Maruyama H, Ebara M. Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma. Int J Clin Oncol 2006;11:258-67. [PMID: 16937299 DOI: 10.1007/s10147-006-0585-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
152 Foley W, Kerimoglu U. Abdominal MDCT: liver, pancreas, and biliary tract. Seminars in Ultrasound, CT and MRI 2004;25:122-44. [DOI: 10.1016/j.sult.2003.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
153 Page AJ, Cosgrove D, Pawlik TM. Comparative effectiveness in hepatic malignancies. Cancer Treat Res 2015;164:195-219. [PMID: 25677025 DOI: 10.1007/978-3-319-12553-4_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Garnier C, Lafon C, Dillenseger JL. 3-D modeling of the thermal coagulation necrosis induced by an interstitial ultrasonic transducer. IEEE Trans Biomed Eng 2008;55:833-7. [PMID: 18270029 DOI: 10.1109/TBME.2007.914543] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
155 Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer. 2010;116:3638-3644. [PMID: 20564097 DOI: 10.1002/cncr.25142] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 7.4] [Reference Citation Analysis]
156 Pacella CM, Bizzarri G, Francica G, Forlini G, Petrolati A, Valle D, Anelli V, Bianchini A, Nuntis SD, Pacella S, Rossi Z, Osborn J, Stasi R. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation. Journal of Hepatology 2006;44:902-9. [DOI: 10.1016/j.jhep.2006.01.031] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
157 Giannini EG, Marenco S, Borgonovo G, Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo M, Benvegnù L, Zoli M. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology. 2012;56:1371-1379. [PMID: 22535689 DOI: 10.1002/hep.25814] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
158 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
159 Guang C, Kawai N, Sato M, Takasaka I, Minamiguchi H, Sahara S, Nakata K, Sonomura T, Shirai S, Mori I, Yang R. Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model. Jpn J Radiol 2011;29:649-55. [PMID: 21956371 DOI: 10.1007/s11604-011-0611-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
160 Higgins MC, Soulen MC. Combining locoregional therapies in the treatment of hepatocellular carcinoma. Semin Intervent Radiol. 2013;30:74-81. [PMID: 24436520 DOI: 10.1055/s-0033-1333656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
161 Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 144] [Article Influence: 14.0] [Reference Citation Analysis]
162 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 684] [Cited by in F6Publishing: 671] [Article Influence: 62.2] [Reference Citation Analysis]
163 Kim DW, Chung K, Chung WK, Bae SH, Shin DO, Hong S, Park SH, Park SY, Hong CS, Lim YK, Shin D, Lee SB, Lee HH, Sung J, Yoon M. Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma. Radiat Oncol 2014;9:109. [PMID: 24886163 DOI: 10.1186/1748-717X-9-109] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
164 Lencioni R. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Crit Rev Oncol Hematol. 2012;83:216-224. [PMID: 22142656 DOI: 10.1016/j.critrevonc.2011.10.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
165 Yoshida H, Yoshida H, Goto E, Sato T, Ohki T, Masuzaki R, Tateishi R, Goto T, Shiina S, Kawabe T. Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma. Hepatol Int. 2008;2:89-94. [PMID: 19669283 DOI: 10.1007/s12072-007-9020-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
166 Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010;2:128-36. [PMID: 21160861 DOI: 10.4240/wjgs.v2.i4.128] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
167 Schullian P, Putzer D, Silva MA, Laimer G, Kolbitsch C, Bale R. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians. Front Oncol 2019;9:929. [PMID: 31608232 DOI: 10.3389/fonc.2019.00929] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
168 Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging. 2009;34:371-380. [PMID: 18463915 DOI: 10.1007/s00261-008-9408-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
169 Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgrò G, Burroughs AK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. Journal of Hepatology 2010;52:380-8. [DOI: 10.1016/j.jhep.2009.12.004] [Cited by in Crossref: 186] [Cited by in F6Publishing: 164] [Article Influence: 16.9] [Reference Citation Analysis]
170 Taefi A, Abrishami A, Nasseri-Moghaddam S, Eghtesad B, Sherman M. Surgical resection versus liver transplant for patients with hepatocellular carcinoma. Cochrane Database Syst Rev 2013;:CD006935. [PMID: 23813393 DOI: 10.1002/14651858.CD006935.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
171 Lin SM, Chu CM. Percutaneous tumor ablation or surgical resection for small hepatocellular carcinoma? J Gastroenterol Hepatol 2007;22:1561-4. [PMID: 17845682 DOI: 10.1111/j.1440-1746.2007.05116.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Albrecht T. HCC-Screening. Radiologe 2008;48:33-8. [DOI: 10.1007/s00117-007-1590-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
173 Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-967. [PMID: 15665226 DOI: 10.1148/radiol.2343040350] [Cited by in Crossref: 608] [Cited by in F6Publishing: 511] [Article Influence: 38.0] [Reference Citation Analysis]
174 Beaugrand M, Trinchet JC. [Non-surgical treatment of hepatocellular carcinoma. An overview]. Cancer Radiother 2005;9:464-9. [PMID: 16236541 DOI: 10.1016/j.canrad.2005.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
175 Kim JH, Kim PN, Won HJ, Shin YM. Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of hepatocellular carcinoma. AJR Am J Roentgenol. 2012;198:471-476. [PMID: 22268196 DOI: 10.2214/ajr.11.6583] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
176 Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-26. [PMID: 18331969 DOI: 10.1102/1470-7330.2008.0004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
177 Hinshaw JL, Laeseke PF, Winter TC, Kliewer MA, Fine JP, Lee FT. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am J Roentgenol. 2006;186:S306-S310. [PMID: 16632692 DOI: 10.2214/ajr.05.0140] [Cited by in Crossref: 53] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
178 Wen T, Jin C, Facciorusso A, Donadon M, Han HS, Mao Y, Dai C, Cheng S, Zhang B, Peng B, Du S, Jia C, Xu F, Shi J, Sun J, Zhu P, Nara S, Millis JM; MDT of West China Hospital*. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr 2018;7:353-71. [PMID: 30498711 DOI: 10.21037/hbsn.2018.08.01] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
179 Bangard C, Gossmann A, Kasper HU, Hellmich M, Fischer JH, Hölscher A, Lackner K, Stippel DL. Experimental Radiofrequency Ablation Near the Portal and the Hepatic Veins in Pigs: Differences in Efficacy of a Monopolar Ablation System. Journal of Surgical Research 2006;135:113-9. [DOI: 10.1016/j.jss.2006.02.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
180 Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J. Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH. Med Clin (Barc) 2021;156:463.e1-463.e30. [PMID: 33461840 DOI: 10.1016/j.medcli.2020.09.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
181 Aubé C, Schmidt D, Brieger J, Schenk M, Kroeber S, Vielle B, Claussen CD, Goldberg SN, Pereira PL. Influence of NaCl Concentrations on Coagulation, Temperature, and Electrical Conductivity Using a Perfusion Radiofrequency Ablation System: An Ex Vivo Experimental Study. Cardiovasc Intervent Radiol 2007;30:92-7. [DOI: 10.1007/s00270-006-0091-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
182 Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009;252:905-13. [PMID: 19567647 DOI: 10.1148/radiol.2523081676] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 12.8] [Reference Citation Analysis]
183 Scartozzi M, Baroni GS, Faloppi L, Paolo MD, Pierantoni C, Candelari R, Berardi R, Antognoli S, Mincarelli C, Risaliti A. Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. J Exp Clin Cancer Res. 2010;29:164. [PMID: 21159184 DOI: 10.1186/1756-9966-29-164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
184 Majno P, Giostra E, Mentha G. Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials? Liver Transpl 2007;13:S27-35. [DOI: 10.1002/lt.21328] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
185 Shi Y, Zhai B. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma. Gastrointest Tumors 2016;3:90-102. [PMID: 27904861 DOI: 10.1159/000445888] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
186 Schoppmeyer K, Weis S, Mössner J, Fleig WE. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst Rev. 2009;3:CD006745. [PMID: 19588401 DOI: 10.1002/14651858.cd006745.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
187 Roxburgh P, Evans TR. Systemic therapy of hepatocellular carcinoma: are we making progress? Adv Ther. 2008;25:1089-1104. [PMID: 18972075 DOI: 10.1007/s12325-008-0113-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
188 Goode JA, Matson MB. Embolisation of cancer: what is the evidence? Cancer Imaging 2004;4:133-41. [PMID: 18250022 DOI: 10.1102/1470-7330.2004.0021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
189 Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford). 2007;9:429-434. [PMID: 18345289 DOI: 10.1080/13651820701713758] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
190 Belli G, D'Agostino A, Fantini C, Cioffi L, Belli A, Russolillo N, Langella S. Laparoscopic radiofrequency ablation combined with laparoscopic liver resection for more than one HCC on cirrhosis. Surg Laparosc Endosc Percutan Tech. 2007;17:331-334. [PMID: 17710062 DOI: 10.1097/SLE.0b013e31806d9c65] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
191 Casadei Gardini A, Marisi G, Canale M, Foschi FG, Donati G, Ercolani G, Valgiusti M, Passardi A, Frassineti GL, Scarpi E. Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival. Onco Targets Ther 2018;11:6555-67. [PMID: 30323628 DOI: 10.2147/OTT.S170836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
192 Chen M, Zhang F, Song J, Weng Q, Li P, Li Q, Qian K, Ji H, Pietrini S, Ji J, Yang X. Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins. Front Oncol 2021;11:593996. [PMID: 34235070 DOI: 10.3389/fonc.2021.593996] [Reference Citation Analysis]
193 Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009;10:333-43. [PMID: 19236203 DOI: 10.1517/14656560802677874] [Cited by in Crossref: 131] [Cited by in F6Publishing: 120] [Article Influence: 10.9] [Reference Citation Analysis]
194 Breen DJ, Lencioni R. Image-guided ablation of primary liver and renal tumours. Nat Rev Clin Oncol. 2015;12:175-186. [PMID: 25601446 DOI: 10.1038/nrclinonc.2014.237] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
195 Odisio BC, Wallace MJ. Image-guided interventions in oncology. Surg Oncol Clin N Am 2014;23:937-55. [PMID: 25246055 DOI: 10.1016/j.soc.2014.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
196 Shiina S, Tateishi R, Imamura M, Teratani T, Koike Y, Sato S, Obi S, Kanai F, Kato N, Yoshida H. Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver Int. 2012;32:1434-1442. [PMID: 22712520 DOI: 10.1111/j.1478-3231.2012.02838.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
197 Llovet JM. Treatment of hepatocellular carcinoma. Curr Treat Options Gastro 2004;7:431-41. [DOI: 10.1007/s11938-004-0002-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
198 Ziemlewicz TJ, Wells SA, Lubner MG, Brace CL, Lee FT Jr, Hinshaw JL. Hepatic Tumor Ablation. Surg Clin North Am 2016;96:315-39. [PMID: 27017867 DOI: 10.1016/j.suc.2015.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
199 Song KD, Lee MW, Park HJ, Cha DI, Kang TW, Lee J, Moon JY, Rhim H. Hepatic radiofrequency ablation: in vivo and ex vivo comparisons of 15-gauge (G) and 17-G internally cooled electrodes. Br J Radiol 2015;88:20140497. [PMID: 25882688 DOI: 10.1259/bjr.20140497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
200 Gillams AR. The use of radiofrequency in cancer. Br J Cancer 2005;92:1825-9. [PMID: 15870717 DOI: 10.1038/sj.bjc.6602582] [Cited by in Crossref: 90] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
201 Stippel DL, Bangard C, Prenzel K, Yavuzyasar S, Fischer JH, Hölscher AH. Which parameters are needed for targeting a multitined radiofrequency device--an approach to a simple algorithm. Langenbecks Arch Surg 2009;394:671-9. [PMID: 18288484 DOI: 10.1007/s00423-008-0306-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
202 Shrimal A, Prasanth M, Kulkarni AV. Interventional radiological treatment of hepatocellular carcinoma: an update. Indian J Surg 2012;74:91-9. [PMID: 23372313 DOI: 10.1007/s12262-011-0377-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
203 Cai DM, Wang HY, Wang XL, Jiang Y, Luo Y, Li YZ. Ultrasonographic findings of small lesion of hepatic alveolar echinococcosis. Acta Trop 2017;174:165-70. [PMID: 26892870 DOI: 10.1016/j.actatropica.2016.01.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
204 Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, Lehnert T, Heller M, Thalhammer A, Mack MG, Vogl TJ. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol 2007;17:553-63. [PMID: 16896704 DOI: 10.1007/s00330-006-0343-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
205 Shiina S. Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatology Research 2007;37:S223-9. [DOI: 10.1111/j.1872-034x.2007.00189.x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
206 Song TJ, Eisenberg DP, Adusumilli PS, Hezel M, Fong Y. Oncolytic herpes viral therapy is effective in the treatment of hepatocellular carcinoma cell lines. J Gastrointest Surg. 2006;10:532-542. [PMID: 16627219 DOI: 10.1016/j.gassur.2005.08.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
207 Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2011;81:e447-e453. [PMID: 21645977 DOI: 10.1016/j.ijrobp.2011.04.011] [Cited by in Crossref: 262] [Cited by in F6Publishing: 216] [Article Influence: 26.2] [Reference Citation Analysis]
208 Shao J, Bai J, Cui L, Wang J, Fu Y, Liu K, Feng S. Elastographic Evaluation of the Temporal Formation of Ethanol-Induced Hepatic Lesions: Preliminary In Vitro Results. Journal of Ultrasound in Medicine 2007;26:1191-9. [DOI: 10.7863/jum.2007.26.9.1191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
209 Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers 2021;7:6. [PMID: 33479224 DOI: 10.1038/s41572-020-00240-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 62] [Article Influence: 96.0] [Reference Citation Analysis]
210 Kirikoshi H, Saito S, Yoneda M, Fujita K, Mawatari H, Uchiyama T, Higurashi T, Goto A, Takahashi H, Abe Y. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma. Hepatol Res. 2009;39:553-562. [PMID: 19527484 DOI: 10.1111/j.1872-034x.2009.00490.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
211 Tranquart F, Claudon M, Correas J. Recommandations pour l’utilisation des agents de contraste ultrasonores. Journal de Radiologie 2005;86:1047-54. [DOI: 10.1016/s0221-0363(05)81492-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
212 European Association for Study of Liver. European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599-641. [PMID: 22424278 DOI: 10.1016/j.ejca.2011.12.021] [Cited by in Crossref: 273] [Cited by in F6Publishing: 255] [Article Influence: 30.3] [Reference Citation Analysis]
213 Beaugrand M, Trinchet JC. Interventional radiology as a fine art. J Hepatol 2007;46:362-4. [PMID: 17239483 DOI: 10.1016/j.jhep.2007.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
214 Takahashi M, Maruyama H, Shimada T, Kamezaki H, Okabe S, Kanai F, Yoshikawa M, Yokosuka O. Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence? Ultrasound Med Biol 2012;38:1902-10. [PMID: 23026230 DOI: 10.1016/j.ultrasmedbio.2012.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
215 Ashoori N, Paprottka P, Trumm C, Bamberg F, Kolligs FT, Rentsch M, Reiser MF, Jakobs TF. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma. Digestion. 2012;85:18-26. [PMID: 22156507 DOI: 10.1159/000334714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
216 Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, Lee JY, Jeon YH, Lee J, Lee SJ. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol. 2005;56:66-73. [PMID: 15913940 DOI: 10.1016/j.ejrad.2005.03.023] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
217 Yamashita T, Kaneko S. Treatment strategies for hepatocellular carcinoma in Japan. Hepatol Res. 2013;43:44-50. [PMID: 22583802 DOI: 10.1111/j.1872-034x.2012.01029.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
218 Ganne-Carrié N, Nault JC, Ziol M, N'Kontchou G, Nahon P, Grando V, Bourcier V, Barge S, Beaugrand M, Trinchet JC, Seror O. Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma. Hepat Oncol 2014;1:395-408. [PMID: 30190975 DOI: 10.2217/hep.14.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
219 Liao GS, Yu CY, Shih ML, Chan DC, Liu YC, Yu JC, Chen TW, Hsieh CB. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:61-66. [PMID: 17434711 DOI: 10.1016/j.ejso.2007.02.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
220 Kwan SW, Kerlan RK Jr, Sunshine JH. Utilization of interventional oncology treatments in the United States. J Vasc Interv Radiol 2010;21:1054-60. [PMID: 20478718 DOI: 10.1016/j.jvir.2010.02.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
221 Chung Y, Han G, Yoon J, Yang J, Wang J, Shao G, Kim BI, Lee T, Chao Y. Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial. Int J Cancer 2013;132:2448-58. [DOI: 10.1002/ijc.27925] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
222 Fernandes ML, Lin CC, Lin CJ, Chen WT, Lin SM. Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation. Br J Surg. 2009;96:756-762. [PMID: 19526609 DOI: 10.1002/bjs.6645] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
223 Qu C, Li XQ, Li C, Xia F, Feng K, Ma K. The Short-Term Efficacy of Novel No-Touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma with Cirrhosis. J Invest Surg 2021;:1-8. [PMID: 34085878 DOI: 10.1080/08941939.2021.1931575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Fong ZV, Tanabe KK. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review: Review of International HCC Guidelines. Cancer 2014;120:2824-38. [DOI: 10.1002/cncr.28730] [Cited by in Crossref: 153] [Cited by in F6Publishing: 146] [Article Influence: 21.9] [Reference Citation Analysis]
225 Higuchi M, Suzuki H, Gotoh M. Role of PET/Computed Tomography in Radiofrequency Ablation for Malignant Pulmonary Tumors. PET Clin 2016;11:47-55. [PMID: 26590443 DOI: 10.1016/j.cpet.2015.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
226 Shibuya A, Nakazawa T, Saigenji K, Furuta K, Matsunaga K. Diaphragmatic hernia after radiofrequency ablation therapy for hepatocellular carcinoma. AJR Am J Roentgenol. 2006;186:S241-S243. [PMID: 16632682 DOI: 10.2214/ajr.04.0931] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
227 Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirasawa K, Koh R, Nihommatsu H, Tanaka K. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 2007;13:1003-9. [PMID: 17373733 DOI: 10.3748/wjg.v13.i7.1003] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
228 Zhang Y, Liang H, Chen M, Guo R, Li J, Zheng Y, Zhang Y, Lau WY. Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial. Radiology 2007;244:599-607. [DOI: 10.1148/radiol.2442060826] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 7.4] [Reference Citation Analysis]
229 Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16:661-669. [PMID: 16228211 DOI: 10.1007/s00330-005-0029-9] [Cited by in Crossref: 155] [Cited by in F6Publishing: 146] [Article Influence: 9.7] [Reference Citation Analysis]
230 Izzo F, Palaia R, Albino V, Amore A, di Giacomo R, Piccirillo M, Leongito M, Nasto A, Granata V, Petrillo A, Lastoria S. Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments. Infect Agent Cancer 2015;10:11. [PMID: 25897320 DOI: 10.1186/s13027-015-0006-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
231 Minami T, Tateishi R, Shiina S, Nakagomi R, Kondo M, Fujiwara N, Mikami S, Sato M, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Kondo Y, Yoshida H, Koike K. Comparison of improved prognosis between hepatitis B- and hepatitis C-related hepatocellular carcinoma: Comparison between HBV- and HCV- related HCC. Hepatol Res 2015;45:E99-E107. [DOI: 10.1111/hepr.12468] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
232 Huo T, Lee S, Wu J. Ethanol injection versus radiofrequency ablation for hepatocellular carcinoma: Which is better? Gastroenterology 2005;128:806-7. [DOI: 10.1053/j.gastro.2005.01.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
233 Zhang G, Yu X, Liu P, Huang X, Jiang X. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis. Dig Dis Sci 2018;63:3207-19. [PMID: 30140982 DOI: 10.1007/s10620-018-5252-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54:1151-1156. [PMID: 16009687 DOI: 10.1136/gut.2004.045203] [Cited by in Crossref: 422] [Cited by in F6Publishing: 358] [Article Influence: 26.4] [Reference Citation Analysis]
235 Staunton M, Dodd JD, McCormick PA, Malone DE. Finding evidence-based answers to practical questions in radiology: which patients with inoperable hepatocellular carcinoma will survive longer after transarterial chemoembolization? Radiology 2005;237:404-13. [PMID: 16244249 DOI: 10.1148/radiol.2372040058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
236 Adán Merino L, Olveira Martín A, Pérez Robledo JP, Prieto I, Gea Rodriguez F, Castillo Grau P, Martín Arranz E, Alonso Gamarra E, Mora Sanz P. [Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma adjacent to the diaphragm]. Gastroenterol Hepatol 2010;33:709-15. [PMID: 21059478 DOI: 10.1016/j.gastrohep.2010.09.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2004;CD003046. [PMID: 15106188 DOI: 10.1002/14651858.cd003046.pub3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
238 Rhee TK, Omary RA, Gates V, Mounajjed T, Larson AC, Barakat O, Sato KT, Mulcahy M, Gordon S, Lewandowski RJ, Salem R. The Effect of Catheter-Directed CT Angiography on Yttrium-90 Radioembolization Treatment of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2005;16:1085-91. [DOI: 10.1097/01.rvi.0000177063.92678.21] [Cited by in Crossref: 49] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
239 Fong Y, Wong J. Evolution in surgery: influence of minimally invasive approaches on the hepatobiliary surgeon. Surg Infect (Larchmt) 2009;10:399-406. [PMID: 19943774 DOI: 10.1089/sur.2009.9936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
240 Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 2008;207:20-29. [PMID: 18589357 DOI: 10.1016/j.jamcollsurg.2008.01.020] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 9.3] [Reference Citation Analysis]
241 Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054-1060. [PMID: 16322950 DOI: 10.1007/s00535-005-1671-3] [Cited by in Crossref: 160] [Cited by in F6Publishing: 141] [Article Influence: 10.7] [Reference Citation Analysis]
242 Ray CE Jr, Battaglia C, Libby AM, Prochazka A, Xu S, Funaki B. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective. J Vasc Interv Radiol. 2012;23:306-314. [PMID: 22277271 DOI: 10.1016/j.jvir.2011.11.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
243 Corey KE, Pratt DS. Current status of therapy for hepatocellular carcinoma. Therap Adv Gastroenterol. 2009;2:45-57. [PMID: 21180533 DOI: 10.1177/1756283X08100328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
244 Lee YC, Hur W, Choi JE, Piao LS, Hong SW, Bae SH, Choi JY, Yoon SK. Analysis of Gene Expression in Primary Hepatocellular Carcinoma Using Differentially Displayed Reverse Transcriptase Polymerase Chain Reaction. Korean J Gastroenterol 2009;53:361. [DOI: 10.4166/kjg.2009.53.6.361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
245 Lin ZZ, Shau WY, Hsu C, Shao YY, Yeh YC, Kuo RN, Hsu CH, Yang JC, Cheng AL, Lai MS. Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size. PLoS One 2013;8:e80276. [PMID: 24244668 DOI: 10.1371/journal.pone.0080276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
246 Sugahara S, Oshiro Y, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Matsuzaki Y, Thono E, Tokita M. Proton beam therapy for large hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:460-466. [PMID: 19427743 DOI: 10.1016/j.ijrobp.2009.02.030] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
247 Rhim H, Lim HK, Kim Y, Choi D. Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial Experience. American Journal of Roentgenology 2008;190:91-8. [DOI: 10.2214/ajr.07.2384] [Cited by in Crossref: 99] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
248 Fartoux L, Arrive L, Andreani T, Serfaty L, Chazouillères O, Tubiana J, Poupon R, Rosmorduc O. Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. Gastroentérologie Clinique et Biologique 2005;29:1213-9. [DOI: 10.1016/s0399-8320(05)82203-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
249 Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:S115-S120. [PMID: 14762851 DOI: 10.1002/lt.20034] [Cited by in Crossref: 459] [Cited by in F6Publishing: 409] [Article Influence: 27.0] [Reference Citation Analysis]
250 Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2005;92:856-858. [PMID: 15892154 DOI: 10.1002/bjs.4986] [Cited by in Crossref: 140] [Cited by in F6Publishing: 106] [Article Influence: 8.8] [Reference Citation Analysis]
251 Giorgio A, Ferraioli G. Radiofrequency thermal ablation versus percutaneous ethanol injection for small hepatocellular carcinoma. Radiology 2004;230:886; author reply 886-7. [PMID: 14990849 DOI: 10.1148/radiol.2303031235] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5:550-560. [PMID: 15337485 DOI: 10.1016/s1470-2045(04)01567-0] [Cited by in Crossref: 135] [Cited by in F6Publishing: 30] [Article Influence: 7.9] [Reference Citation Analysis]
253 Cha CH, Saif MW, Yamane BH, Weber SM. Hepatocellular carcinoma: Current management. Curr Probl Surg. 2010;47:10-67. [PMID: 19963083 DOI: 10.1067/j.cpsurg.2009.09.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
254 Yin X, Xie X, Lu M, Xu H, Xu Z, Kuang M, Liu G, Liang J, Lau WY. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: Long-term outcome and prognostic factors. Cancer 2009;115:1914-23. [DOI: 10.1002/cncr.24196] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 8.3] [Reference Citation Analysis]
255 Kuang M, Lu MD, Xie XY, Xu HX, Xu ZF, Liu GJ, Yin XY, Huang JF, Lencioni R. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy. Radiology. 2009;253:552-561. [PMID: 19709992 DOI: 10.1148/radiol.2532082021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
256 Colombo M, Iavarone M. Role of antiviral treatment for HCC prevention. Best Pract Res Clin Gastroenterol 2014;28:771-81. [PMID: 25260307 DOI: 10.1016/j.bpg.2014.07.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
257 Dufour JF, Johnson P. Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference. J Hepatol 2010;52:296-304. [PMID: 20006399 DOI: 10.1016/j.jhep.2009.11.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
258 Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G. Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center. American Journal of Roentgenology 2005;184:207-11. [DOI: 10.2214/ajr.184.1.01840207] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 4.8] [Reference Citation Analysis]
259 Lin S, Lin C, Chen W, Chen Y, Hsu C. Radiofrequency Ablation for Hepatocellular Carcinoma: A Prospective Comparison of Four Radiofrequency Devices. Journal of Vascular and Interventional Radiology 2007;18:1118-25. [DOI: 10.1016/j.jvir.2007.06.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
260 Livraghi T. Single HCC smaller than 2 cm: surgery or ablation: interventional oncologist’s perspective. J Hepatobiliary Pancreat Sci. 2010;17:425-429. [PMID: 19890600 DOI: 10.1007/s00534-009-0244-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
261 Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: An updated review. World J Gastrointest Pharmacol Ther 2016;7:477-89. [PMID: 27867681 DOI: 10.4292/wjgpt.v7.i4.477] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 55] [Article Influence: 12.6] [Reference Citation Analysis]
262 Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology. 2004;127:1714-1723. [PMID: 15578509 DOI: 10.1053/j.gastro.2004.09.003] [Cited by in Crossref: 445] [Cited by in F6Publishing: 374] [Article Influence: 27.8] [Reference Citation Analysis]
263 Schirmang TC, Dupuy DE. Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip™ radiofrequency ablation system. Expert Review of Medical Devices 2014;4:803-14. [DOI: 10.1586/17434440.4.6.803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
264 Miyamoto N, Hiramatsu K, Tsuchiya K, Sato Y. Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: treatment of patients with local progression of hepatocellular carcinoma. Radiat Med. 2008;26:92-97. [PMID: 18301986 DOI: 10.1007/s11604-007-0198-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
265 Abitabile P, Maurer CA. Radiofrequency ablation of liver tumors: a novel needle perfusion technique enhances efficiency. J Surg Res. 2010;159:532-537. [PMID: 19394647 DOI: 10.1016/j.jss.2008.08.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
266 Gillams AR. Liver ablation therapy. BJR 2004;77:713-23. [DOI: 10.1259/bjr/86761907] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
267 Kim YJ, Raman SS, Yu NC, Lu DS. MR-guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2T open MR system. J Magn Reson Imaging 2005;22:566-71. [PMID: 16161074 DOI: 10.1002/jmri.20408] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
268 Pua BB, Sofocleous CT. Imaging to optimize liver tumor ablation. Imaging Med 2010;2:433-43. [PMID: 27840657 DOI: 10.2217/IIM.10.32] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
269 Rhee TK, Larson AC, Prasad PV, Santos E, Sato KT, Salem R, Deng J, Paunesku T, Woloschak GE, Mulcahy MF, Li D, Omary RA. Feasibility of Blood Oxygenation Level–dependent MR Imaging to Monitor Hepatic Transcatheter Arterial Embolization in Rabbits. Journal of Vascular and Interventional Radiology 2005;16:1523-8. [DOI: 10.1097/01.rvi.0000182179.87340.d7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
270 Mendizabal M, Reddy KR. Current Management of Hepatocellular Carcinoma. Medical Clinics of North America 2009;93:885-900. [DOI: 10.1016/j.mcna.2009.03.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
271 Zhao J, Qian L, Zu Y, Wei Y, Hu X. Efficacy of Ablation Therapy for Secondary Hyperparathyroidism by Ultrasound Guided Percutaneous Thermoablation. Ultrasound Med Biol 2016;42:1058-65. [PMID: 26944529 DOI: 10.1016/j.ultrasmedbio.2015.08.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
272 Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11-17. [PMID: 19924474 DOI: 10.1007/s00270-009-9736-y] [Cited by in Crossref: 165] [Cited by in F6Publishing: 149] [Article Influence: 15.0] [Reference Citation Analysis]
273 Müller C, Schöniger-hekele M, Schernthaner R, Renner B, Peck-radosavljevic M, Brichta A, Wrba F, Posch M, Bauer P, Ferenci P, Gangl A. Percutaneous ethanol instillation therapy for hepatocellular carcinoma – a randomized controlled trial. Wien Klin Wochenschr 2008;120:608-18. [DOI: 10.1007/s00508-008-1086-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
274 Takeda A, Sanuki N, Tsurugai Y, Iwabuchi S, Matsunaga K, Ebinuma H, Imajo K, Aoki Y, Saito H, Kunieda E. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Cancer. 2016;122:2041-2049. [PMID: 27062278 DOI: 10.1002/cncr.30008] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 19.2] [Reference Citation Analysis]
275 Hasegawa K, Kokudo N, Sano K, Makuuchi M. Single HCC between 2 and 5 cm: the grey zone: surgeon's perspective. J Hepatobiliary Pancreat Sci 2010;17:430-3. [PMID: 19890599 DOI: 10.1007/s00534-009-0245-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
276 Zhu G, Sun M, Liao W, Yu W, Zhou S, Zhou Z, Shi Y, Fan J, Zhou J, Qiu L, Dai Z. Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 2018;12:935-45. [DOI: 10.1080/17474124.2018.1503531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
277 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 115] [Article Influence: 13.3] [Reference Citation Analysis]
278 Tang C, Shen J, Feng W, Bao Y, Dong X, Dai Y, Zheng Y, Zhang J. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study. Medicine (Baltimore) 2016;95:e3754. [PMID: 27196501 DOI: 10.1097/MD.0000000000003754] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
279 Girotra M, Soota K, Dhaliwal AS, Abraham RR, Garcia-Saenz-de-Sicilia M, Tharian B. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging? World J Gastrointest Endosc. 2018;10:56-68. [PMID: 29467916 DOI: 10.4253/wjge.v10.i2.56] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
280 Gory I, Fink M, Bell S, Gow P, Nicoll A, Knight V, Dev A, Rode A, Bailey M, Cheung W. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study. Scand J Gastroenterol. 2015;50:567-576. [PMID: 25615260 DOI: 10.3109/00365521.2014.953572] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
281 Colombo M, Sangiovanni A. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2015;35 Suppl 1:129-138. [PMID: 25529098 DOI: 10.1111/liv.12713] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
282 Han JK, Lee JM, Kim SH, Lee JY, Park HS, Eo H, Choi BI. Radiofrequency ablation in the liver using two cooled-wet electrodes in the bipolar mode. Eur Radiol 2005;15:2163-70. [DOI: 10.1007/s00330-005-2713-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
283 Yin XY, Xie XY, Lu MD, Kuang M, Liu GJ, Xu ZF, Xu HX, Wang Z. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model. Ann Surg Oncol. 2012;19:4300-4306. [PMID: 22766980 DOI: 10.1245/s10434-012-2433-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
284 Park EK, Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Kim JW, Cho CK. A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Ann Surg Treat Res 2014;87:72-80. [PMID: 25114886 DOI: 10.4174/astr.2014.87.2.72] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
285 Abdo AA, Hassanain M, AlJumah A, Al Olayan A, Sanai FM, Alsuhaibani HA, Abdulkareem H, Abdallah K, AlMuaikeel M, Al Saghier M, Babatin M, Kabbani M, Bazarbashi S, Metrakos P, Bruix J; Saudi Association for the Study of Liver Diseases and Transplantation., Saudi Oncology Society. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med 2012;32:174-99. [PMID: 22366832 DOI: 10.5144/0256-4947.2012.174] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
286 Deng J, Miller FH, Rhee TK, Sato KT, Mulcahy MF, Kulik LM, Salem R, Omary RA, Larson AC. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol. 2006;17:1195-1200. [PMID: 16868174 DOI: 10.1097/01.rvi.0000227234.81718.eb] [Cited by in Crossref: 81] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
287 Kim YI, Chung JW. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery. Expert Rev Gastroenterol Hepatol 2008;2:791-802. [PMID: 19090739 DOI: 10.1586/17474124.2.6.791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
288 Fietta AM, Morosini M, Passadore I, Cascina A, Draghi P, Dore R, Rossi S, Pozzi E, Meloni F. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol 2009;70:477-86. [PMID: 19332094 DOI: 10.1016/j.humimm.2009.03.012] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
289 Galle PR, Tovoli F, Foerster F, Wörns MA, Cucchetti A, Bolondi L. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. Journal of Hepatology 2017;67:173-83. [DOI: 10.1016/j.jhep.2017.03.007] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 17.3] [Reference Citation Analysis]
290 Trinchet J. Carcinome hépatocellulaire : une incidence croissante, une prise en charge « optimisée ». Gastroentérologie Clinique et Biologique 2009;33:830-9. [DOI: 10.1016/j.gcb.2009.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
291 Poggi G, Tosoratti N, Montagna B, Picchi C. Microwave ablation of hepatocellular carcinoma. World J Hepatol 2015;7:2578-89. [PMID: 26557950 DOI: 10.4254/wjh.v7.i25.2578] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
292 Choi D, Lim HK, Kim MJ, Kim SJ, Kim SH, Lee WJ, Lim JH, Paik SW, Yoo BC, Choi MS, Kim S. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol. 2005;184:1860-1867. [PMID: 15908543 DOI: 10.2214/ajr.184.6.01841860] [Cited by in Crossref: 78] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
293 Zhang L, Yin X, Gan YH, Zhang BH, Zhang JB, Chen Y, Xie XY, Ge NL, Wang YH, Ye SL. Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol. 2014;14:11. [PMID: 24410841 DOI: 10.1186/1471-230x-14-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
294 Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-73. [DOI: 10.1002/hep.23725] [Cited by in Crossref: 323] [Cited by in F6Publishing: 302] [Article Influence: 29.4] [Reference Citation Analysis]
295 Hsieh Y, Limquiaco JL, Lin C, Chen W, Lin S. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations. Abdom Radiol 2019;44:1141-51. [DOI: 10.1007/s00261-018-1831-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
296 Park W, Lim DH, Paik SW, Koh KC, Choi MS, Park CK, Yoo BC, Lee JE, Kang MK, Park YJ. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:1143-1150. [PMID: 15752895 DOI: 10.1016/j.ijrobp.2004.08.028] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
297 Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005;11:1117-1126. [PMID: 16123960 DOI: 10.1002/lt.20469] [Cited by in Crossref: 136] [Cited by in F6Publishing: 125] [Article Influence: 8.5] [Reference Citation Analysis]
298 Saverio Ferrari F, Stella A, Pasquinucci P, Vigni F, Civeli L, Pieraccini M, Magnolfi F. Treatment of small hepatocellular carcinoma: a comparison of techniques and long-term results: . European Journal of Gastroenterology & Hepatology 2006;18:659-72. [DOI: 10.1097/00042737-200606000-00014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
299 Branco F, Brú C, Vilana R, Bianchi L, Alves de Mattos A. Percutaneous ethanol injection before liver transplantation in the hepatocellular carcinoma. Annals of Hepatology 2009;8:220-7. [DOI: 10.1016/s1665-2681(19)31769-7] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
300 Lin Y, Wen Q, Guo L, Wang H, Sui G, Sun Z. A network meta-analysis on the efficacy and prognosis of different interventional therapies for early-stage hepatocellular carcinoma. Int J Hyperthermia 2018;35:450-62. [PMID: 30354777 DOI: 10.1080/02656736.2018.1507047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
301 Giovannini M. Le traitement percutané du carcinome hépato-cellulaire. Gastroentérologie Clinique et Biologique 2007;31:347-53. [DOI: 10.1016/s0399-8320(07)89388-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
302 Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, Ohyama K, Hosho K, Murawaki Y. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation. Clinical Imaging 2010;34:60-4. [DOI: 10.1016/j.clinimag.2009.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
303 Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kishimoto Y, Okubo Y, Makino H, Tsukamoto N, Igarashi Y. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study. World J Gastroenterol. 2015;21:13490-13499. [PMID: 26730160 DOI: 10.3748/wjg.v21.i48.13490] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
304 Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113-S119. [PMID: 16286887 DOI: 10.1097/01.tp.0000187109.69663.93] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
305 Esneault S, Hraiech N, Delabrousse E, Dillenseger JL. Graph cut liver segmentation for interstitial ultrasound therapy. Annu Int Conf IEEE Eng Med Biol Soc 2007;2007:5247-50. [PMID: 18003191 DOI: 10.1109/IEMBS.2007.4353525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
306 Mizumoto M, Oshiro Y, Okumura T, Fukumitsu N, Numajiri H, Ohnishi K, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience. Int J Part Ther 2016;2:570-8. [PMID: 31772968 DOI: 10.14338/IJPT-15-00035.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
307 Morimoto M, Numata K, Kondo M, Moriya S, Morita S, Maeda S, Tanaka K. Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: a prospective cohort study. Eur J Radiol. 2013;82:497-503. [PMID: 23068563 DOI: 10.1016/j.ejrad.2012.09.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
308 Lerut J. Carcinome hépatocellulaire et transplantation hépatique : état des lieux. Journal de Chirurgie 2007;144:105-10. [DOI: 10.1016/s0021-7697(07)89481-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
309 Pompili M, Nicolardi E, Abbate V, Miele L, Riccardi L, Covino M, De Matthaeis N, Grieco A, Landolfi R, Rapaccini GL. Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol 2011;17:3126-32. [PMID: 21912455 DOI: 10.3748/wjg.v17.i26.3126] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
310 Yin X, Lu M. Percutaneous ablation for small hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;3:121-30. [DOI: 10.1586/egh.09.7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
311 Yamakado K, Nakatsuka A, Akeboshi M, Takaki H, Takeda K. Percutaneous radiofrequency ablation for the treatment of liver neoplasms in the caudate lobe left of the vena cava: electrode placement through the left lobe of the liver under CT-fluoroscopic guidance. Cardiovasc Intervent Radiol 2005;28:638-40. [PMID: 16132396 DOI: 10.1007/s00270-004-0104-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
312 Seror O, Haddar D, N'kontchou G, Ajavon Y, Trinchet J, Beaugrand M, Sellier N. Radiofrequency Ablation for the Treatment of Liver Tumors in the Caudate Lobe. Journal of Vascular and Interventional Radiology 2005;16:981-90. [DOI: 10.1097/01.rvi.0000159859.71448.8a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
313 Seror O, N'Kontchou G, Tin Tin Htar M, Durand-Zaleski I, Trinchet JC, Sellier N, Beaugrand M. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost. Gastroenterol Clin Biol. 2006;30:1265-1273. [PMID: 17185968 DOI: 10.1016/S0399-8320(06)73534-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
314 Shields A, Reddy KR. Hepatocellular carcinoma: current treatment strategies. Curr Treat Options Gastroenterol 2005;8:457-66. [PMID: 16313863 DOI: 10.1007/s11938-005-0032-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
315 Xu G, Jin B, Xian X, Yang H, Zhao H, Du S, Makuuchi M, Pawlik TM, Mao Y. Evolutions in the Management of Hepatocellular Carcinoma over Last 4 Decades: An Analysis from the 100 Most Influential Articles in the Field. Liver Cancer 2021;10:137-50. [PMID: 33977090 DOI: 10.1159/000513412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Sharr WW, Chan SC, Lo CM. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation. Transplantation. 2014;97 Suppl 8:S10-S17. [PMID: 24849822 DOI: 10.1097/01.tp.0000446267.19148.21] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
317 Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J; for the Barcelona Cly'nic Liver Cancer (BCLC) Group. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-60. [DOI: 10.1002/hep.20465] [Cited by in Crossref: 330] [Cited by in F6Publishing: 280] [Article Influence: 19.4] [Reference Citation Analysis]
318 Su M, Zhao Y, Liu J. The role of definitive local treatment in metastatic hepatocellular carcinoma patients: A SEER-based study. Medicine (Baltimore) 2018;97:e0020. [PMID: 29517658 DOI: 10.1097/MD.0000000000010020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Ahn J, Flamm SL. Hepatocellular carcinoma. Dis Mon 2004;50:556-73. [PMID: 15616490 DOI: 10.1016/j.disamonth.2004.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
320 Laeseke PF, Sampson LA, Haemmerich D, Brace CL, Fine JP, Frey TM, Winter TC 3rd, Lee FT Jr. Multiple-electrode radiofrequency ablation: simultaneous production of separate zones of coagulation in an in vivo porcine liver model. J Vasc Interv Radiol 2005;16:1727-35. [PMID: 16371542 DOI: 10.1097/01.rvi.000018362.17771.b0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
321 Chu MO, Shen CH, Chang TS, Xu HW, Yen CW, Lu SN, Hung CH. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation. Sci Rep 2018;8:16611. [PMID: 30413724 DOI: 10.1038/s41598-018-34543-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
322 Karani JB, Yu DF, Kane PA. Interventional Radiology in Liver Transplantation. Cardiovasc Intervent Radiol 2005;28:271-83. [DOI: 10.1007/s00270-004-0074-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
323 Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:514-524. [PMID: 19174803 DOI: 10.1038/ajg.2008.80] [Cited by in Crossref: 166] [Cited by in F6Publishing: 144] [Article Influence: 13.8] [Reference Citation Analysis]
324 Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008;48 Suppl 1:S20-S37. [PMID: 18304676 DOI: 10.1016/j.jhep.2008.01.022] [Cited by in Crossref: 576] [Cited by in F6Publishing: 552] [Article Influence: 44.3] [Reference Citation Analysis]
325 Hartmann E, Németh A, Juharosi G, Lénárd Z, Deák PÁ, Kozma V, Nagy P, Gerlei Z, Fehérvári I, Nemes B, Görög D, Fazakas J, Kóbori L, Doros A. Downstaging of hepatocellular carcinoma with radiofrequency ablation on the Hungarian liver transplantation waiting list — Early results and learned lessons. IMAS 2009;1:41-5. [DOI: 10.1556/imas.1.2009.1.6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
326 Santi V, Trevisani F, Gramenzi A, Grignaschi A, Mirici-Cappa F, Del Poggio P, Di Nolfo MA, Benvegnù L, Farinati F, Zoli M. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol. 2010;53:291-297. [PMID: 20483497 DOI: 10.1016/j.jhep.2010.03.010] [Cited by in Crossref: 184] [Cited by in F6Publishing: 161] [Article Influence: 16.7] [Reference Citation Analysis]
327 Inoue T, Kudo M, Hatanaka K, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Minami Y, Sakurai T. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology. 2013;84 Suppl 1:51-57. [PMID: 23428859 DOI: 10.1159/000345890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
328 Yamashita H, Nakagawa K, Shiraishi K, Tago M, Igaki H, Nakamura N, Sasano N, Shiina S, Omata M, Ohtomo K. External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. J Gastroenterol Hepatol 2006;21:1555-60. [PMID: 16928216 DOI: 10.1111/j.1440-1746.2006.04432.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
329 de Baere T, Deschamps F, Briggs P, Dromain C, Boige V, Hechelhammer L, Abdel-rehim M, Aupérin A, Goere D, Elias D. Hepatic Malignancies: Percutaneous Radiofrequency Ablation during Percutaneous Portal or Hepatic Vein Occlusion. Radiology 2008;248:1056-66. [DOI: 10.1148/radiol.2483070222] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
330 Bryce K, Tsochatzis EA. Downstaging for hepatocellular cancer: harm or benefit? Transl Gastroenterol Hepatol. 2017;2:106. [PMID: 29354763 DOI: 10.21037/tgh.2017.11.18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
331 Tsai W, Cheng J, Lai K, Lin C, Lo G, Hsu P, Yu H, Lin C, Chan H, Chen W, Chen T, Li W, Liang H. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - a long-term follow-up study. Alimentary Pharmacology & Therapeutics 2008;28:304-11. [DOI: 10.1111/j.1365-2036.2008.03702.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
332 Zygmont ME, Lam DL, Nowitzki KM, Burton KR, Lenchik L, Mcarthur TA, Sekhar AK, Itri JN. Opportunities for Patient-centered Outcomes Research in Radiology. Academic Radiology 2016;23:8-17. [DOI: 10.1016/j.acra.2015.08.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
333 Ng KK, Poon RT. Role of radiofrequency ablation for liver malignancies. Surgical Practice 2005;9:94-103. [DOI: 10.1111/j.1744-1633.2005.00265.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
334 Meza-Junco J, Montano-Loza AJ, Liu DM, Sawyer MB, Bain VG, Ma M, Owen R. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how? Cancer Treat Rev 2012;38:54-62. [PMID: 21726960 DOI: 10.1016/j.ctrv.2011.05.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
335 Craxì A, Cammà C. Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons. Dig Liver Dis. 2010;42 Suppl 3:S287-S292. [PMID: 20547316 DOI: 10.1016/s1590-8658(10)60518-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
336 Ahrar K, Newman RA, Pang J, Vijjeswarapu MK, Wallace MJ, Wright KC. 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2004;15:901-905. [PMID: 15361556 DOI: 10.1097/01.rvi.0000136829.36643.ed] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
337 Petrowsky H, Busuttil RW. Resection or ablation of small hepatocellular carcinoma: what is the better treatment? J Hepatol. 2008;49:502-504. [PMID: 18706732 DOI: 10.1016/j.jhep.2008.07.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
338 Ho C, Kachura J, Gallinger S, Grant D, Greig P, Mcgilvray I, Knox J, Sherman M, Wong F, Wong D. Percutaneous Ethanol Injection of Unresectable Medium-to-Large-Sized Hepatomas Using a Multipronged Needle: Efficacy and Safety. Cardiovasc Intervent Radiol 2007;30:241-7. [DOI: 10.1007/s00270-005-0169-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
339 Gans JH, Lipman J, Golowa Y, Kinkhabwala M, Kaubisch A. Hepatic Cancers Overview: Surgical and Chemotherapeutic Options, How Do Y-90 Microspheres Fit in? Seminars in Nuclear Medicine 2019;49:170-81. [DOI: 10.1053/j.semnuclmed.2019.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
340 Lencioni R, Cioni D, Pina CD, Crocetti L. Hepatocellular carcinoma: new options for image-guided ablation. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:399-403. [DOI: 10.1007/s00534-009-0233-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
341 Thamtorawat S, Hicks RM, Yu J, Siripongsakun S, Lin WC, Raman SS, McWilliams JP, Douek M, Bahrami S, Lu DS. Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier? J Vasc Interv Radiol. 2016;27:623-630. [PMID: 27013403 DOI: 10.1016/j.jvir.2016.01.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
342 Tremosini S, Reig M, de Lope CR, Forner A, Bruix J. Treatment of early hepatocellular carcinoma: Towards personalized therapy. Dig Liver Dis. 2010;42 Suppl 3:S242-S248. [PMID: 20547310 DOI: 10.1016/s1590-8658(10)60512-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
343 Goh AS, Chung AY, Lo RH, Lau TN, Yu SW, Chng M, Satchithanantham S, Loong SL, Ng DC, Lim BC. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device--a first-in-man study. Int J Radiat Oncol Biol Phys. 2007;67:786-792. [PMID: 17141975 DOI: 10.1016/j.ijrobp.2006.09.011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
344 Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. Hepatocellular Carcinoma: Current Management and Perspectives for the Future. Annals of Surgery 2011;253:453-69. [DOI: 10.1097/sla.0b013e31820d944f] [Cited by in Crossref: 282] [Cited by in F6Publishing: 162] [Article Influence: 28.2] [Reference Citation Analysis]
345 Lencioni R, Crocetti L, Cioni D, Pina CD, Oliveri F, De Simone P, Brunetto M, Filipponi F. Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study. J Vasc Interv Radiol. 2010;21:1533-1538. [PMID: 20817558 DOI: 10.1016/j.jvir.2010.06.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
346 Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684-692. [PMID: 17093964 DOI: 10.1007/s00330-006-0461-5] [Cited by in Crossref: 229] [Cited by in F6Publishing: 205] [Article Influence: 15.3] [Reference Citation Analysis]
347 Maher MM, Hodnett PA, Kalra MK. Evidence-based Practice in Radiology: Steps 3 and 4—Appraise and Apply Interventional Radiology Literature. Radiology 2007;242:658-70. [DOI: 10.1148/radiol.2423060008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
348 Ikemoto T, Shimada M, Yamada S. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation. Hepatol Res. 2017;47:23-30. [PMID: 26990590 DOI: 10.1111/hepr.12705] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
349 Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol. 2008;15:2757-2764. [PMID: 18618182 DOI: 10.1245/s10434-008-0043-7] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 8.0] [Reference Citation Analysis]
350 Zhang YJ, Chen MS. Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma. World J Hepatol 2010;2:146-50. [PMID: 21160987 DOI: 10.4254/wjh.v2.i4.146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
351 Kawashima M, Furuse J, Nishio T, Konishi M, Ishii H, Kinoshita T, Nagase M, Nihei K, Ogino T. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol. 2005;23:1839-1846. [PMID: 15774777 DOI: 10.1200/jco.2005.00.620] [Cited by in Crossref: 152] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
352 Theodoropoulos J, Brooks A. Inconsistency in the Management of Patients with Hepatocellular Carcinoma: The Need for a Strict Protocol. The American Surgeon 2011;77:207-14. [DOI: 10.1177/000313481107700223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
353 Tinkle CL, Haas-Kogan D. Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics 2012;6:207-19. [PMID: 22904613 DOI: 10.2147/BTT.S23907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 25] [Article Influence: 0.6] [Reference Citation Analysis]
354 Zangos S, Mack MG, Balzer J, Engelmann K, Straub R, Eichler K, Herzog C, Lehnert T, Söllner O, Heller M, Thalhammer A, Vogl TJ. Neoadjuvant Transarterial Chemoembolization (TACE) before Percutaneous MR-guided Laser-induced Thermotherapy (LITT): Results in Large-sized Primary and Secondary Liver Tumors. Medical Laser Application 2004;19:98-108. [DOI: 10.1078/1615-1615-00130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
355 Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2011;98:1210-1224. [PMID: 21766289 DOI: 10.1002/bjs.7669] [Cited by in Crossref: 170] [Cited by in F6Publishing: 161] [Article Influence: 17.0] [Reference Citation Analysis]
356 Knight SR, Friend PJ, Morris PJ. Role of transplantation in the management of hepatic malignancy. British Journal of Surgery 2007;94:1319-30. [DOI: 10.1002/bjs.5968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
357 Yang B, Zan RY, Wang SY, Li XL, Wei ML, Guo WH, You X, Li J, Liao ZY. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials. World J Surg Oncol. 2015;13:96. [PMID: 25889181 DOI: 10.1186/s12957-015-0516-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
358 Kawasoe H, Eguchi Y, Mizuta T, Yasutake T, Ozaki I, Shimonishi T, Miyazaki K, Tamai T, Kato A, Kudo S, Fujimoto K. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr 2007;40:66-72. [PMID: 18437215 DOI: 10.3164/jcbn.40.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
359 Baldan A, Marino D, De Giorgio M, Angonese C, Cillo U, D'alessandro A, Masotto A, Massani M, Mazzucco M, Miola E, Neri D, Paccagnella D, Pivetta G, Stellato A, Tommasi L, Tremolada F, Tufano A, Zanus G, Farinati F; ON BEHALF OF GENE – GRUPPO EPATOCARCINOMA NORD-EST1. Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. Aliment Pharmacol Ther 2006;24:1495-501. [DOI: 10.1111/j.1365-2036.2006.03136.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
360 Kotoh K, Morizono S, Kohjima M, Enjoji M, Sakai H, Nakamuta M. Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model. Liver Int 2005;25:1217-23. [DOI: 10.1111/j.1478-3231.2005.01167.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
361 Zhou P, Kudo M, Minami Y, Chung H, Inoue T, Fukunaga T, Maekawa K. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Oncology. 2007;72 Suppl 1:92-97. [PMID: 18087188 DOI: 10.1159/000111713] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
362 Peng ZW, Liang HH, Chen MS, Zhang YJ, Li JQ, Zhang YQ, Lau WY. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe. Eur J Surg Oncol 2008;34:166-72. [PMID: 17851020 DOI: 10.1016/j.ejso.2007.08.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
363 Lin YH, Chiou YY, Chou YH, Chau GY, Wang HK, Chiang JH, Chang CY. Radiofrequency ablation for recurrent hepatocellular carcinoma in postresectional patients: prognostic factors analysis. Eur J Gastroenterol Hepatol 2011;23:1239-44. [PMID: 21941191 DOI: 10.1097/MEG.0b013e32834c5b13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
364 Cohen EI, Field D, Lynskey GE, Kim AY. Technology of irreversible electroporation and review of its clinical data on liver cancers. Expert Rev Med Devices 2018;15:99-106. [PMID: 29307242 DOI: 10.1080/17434440.2018.1425612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
365 Landman MP, Feurer ID, Pinson CW, Moore DE. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria? HPB (Oxford) 2011;13:783-91. [PMID: 21999591 DOI: 10.1111/j.1477-2574.2011.00355.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
366 Hernandez-Gea V, Turon F, Berzigotti A, Villanueva A. Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. World J Gastroenterol. 2013;19:1193-1199. [PMID: 23482437 DOI: 10.3748/wjg.v19.i8.1193] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
367 Braga L, Guller U, Semelka RC. Pre-, peri-, and posttreatment imaging of liver lesions. Radiol Clin North Am 2005;43:915-27, viii. [PMID: 16098347 DOI: 10.1016/j.rcl.2005.05.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
368 Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver 2010;4 Suppl 1:S113-8. [PMID: 21103289 DOI: 10.5009/gnl.2010.4.S1.S113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
369 Wells SA, Hinshaw JL, Lubner MG, Ziemlewicz TJ, Brace CL, Lee FT Jr. Liver Ablation: Best Practice. Radiol Clin North Am 2015;53:933-71. [PMID: 26321447 DOI: 10.1016/j.rcl.2015.05.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
370 Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Yoshida H, Omata M. Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 2008;103:3057-62. [DOI: 10.1111/j.1572-0241.2008.02153.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
371 Wong N, Haydon A, Kemp W, Wijeratne P, Roberts S. Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009. Intern Med J 2013;43:197-203. [PMID: 22372378 DOI: 10.1111/j.1445-5994.2012.02755.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
372 Majumdar A, Roccarina D, Thorburn D, Davidson BR, Tsochatzis E, Gurusamy KS. Management of people with early- or very early-stage hepatocellular carcinoma: An attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3:CD011650. [PMID: 28351116 DOI: 10.1002/14651858.cd011650.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
373 Head HW, Dodd GD 3rd. Thermal ablation for hepatocellular carcinoma. Gastroenterology. 2004;127:S167-S178. [PMID: 15508081 DOI: 10.1053/j.gastro.2004.09.031] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
374 Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, Tatsumi C, Minami Y, Ueshima K, Fukunaga T. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis. 2007;25:303-309. [PMID: 17960064 DOI: 10.1159/000106909] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
375 Livraghi T, Brambilla G, Carnaghi C, Tommasini MA, Torzilli G. Is it time to reconsider the BCLC/AASLD therapeutic flow-chart? J Surg Oncol. 2010;102:868-876. [PMID: 20886553 DOI: 10.1002/jso.21733] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
376 Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am 2010;24:899-919, viii. [PMID: 20937457 DOI: 10.1016/j.idc.2010.07.004] [Cited by in Crossref: 120] [Cited by in F6Publishing: 100] [Article Influence: 12.0] [Reference Citation Analysis]
377 Belli G, Cioffi L, Fantini C, D’Agostino A, Russo G, Limongelli P, Belli A. Laparoscopic redo surgery for recurrent hepatocellular carcinoma in cirrhotic patients: feasibility, safety, and results. Surg Endosc. 2009;23:1807-1811. [PMID: 19277781 DOI: 10.1007/s00464-009-0344-3] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
378 Iavarone M, Colombo M. HBV-related HCC, clinical issues and therapy. Dig Liver Dis. 2011;43 Suppl 1:S32-S39. [PMID: 21195370 DOI: 10.1016/S1590-8658(10)60690-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
379 Lin CC, Cheng YT, Chen M WT, Lin SM. The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2. Liver Cancer 2016;5:8-20. [PMID: 26989656 DOI: 10.1159/000367755] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
380 Del Gaudio M, Ercolani G, Ravaioli M, Cescon M, Lauro A, Vivarelli M, Zanello M, Cucchetti A, Vetrone G, Tuci F. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant. 2008;8:1177-1185. [PMID: 18444925 DOI: 10.1111/j.1600-6143.2008.02229.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
381 Davis CR. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010;17:87-99. [PMID: 20404792 DOI: 10.1177/107327481001700204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
382 Gillams AR. Image guided tumour ablation. Cancer Imaging. 2005;5:103-109. [PMID: 16305946 DOI: 10.1102/1470-7330.2005.0015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
383 Livraghi T, Meloni F, Morabito A, Vettori C. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl. 2004;10:S98-106. [PMID: 14762848 DOI: 10.1002/lt.20053] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
384 Kulik LM. Advancements in hepatocellular carcinoma: . Current Opinion in Gastroenterology 2007;23:268-74. [DOI: 10.1097/mog.0b013e3280ec5113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
385 Li D, Kang J, Madoff DC. Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther. 2014;14:931-945. [PMID: 24746315 DOI: 10.1586/14737140.2014.911091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
386 Park MH, Rhim H, Kim YS, Choi D, Lim HK, Lee WJ. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics. 2008;28:379-390; discussion 390-392. [PMID: 18349446 DOI: 10.1148/rg.282075038] [Cited by in Crossref: 99] [Cited by in F6Publishing: 78] [Article Influence: 7.6] [Reference Citation Analysis]
387 Lin JW, Lin CC, Chen WT, Lin SM. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations. Kaohsiung J Med Sci 2014;30:396-401. [PMID: 25002377 DOI: 10.1016/j.kjms.2014.04.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
388 Hagel AF, Hagel WH, Lindner AS, Kammerer FJ, Neurath MF, Konturek PC, Harsch IA. Metastatic insulinoma - prolonged survival after multimodal approach. Med Sci Monit 2011;17:CS103-107. [PMID: 21804467 DOI: 10.12659/msm.881891] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
389 Weinstein JL, Ahmed M. Percutaneous Ablation for Hepatocellular Carcinoma. AJR Am J Roentgenol 2018;210:1368-75. [PMID: 29702018 DOI: 10.2214/AJR.17.18695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
390 Park Y, Kim YS, Rhim H, Lim HK, Choi D, Lee WJ. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression. AJR Am J Roentgenol. 2009;193:757-763. [PMID: 19696290 DOI: 10.2214/ajr.08.2202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
391 Helmberger T, Hoffmann RT, Jakobs T, Leibecke T, Lubienski A, Reiser M. [Liver tumor ablation]. Radiologe. 2005;45:55-62. [PMID: 15609015 DOI: 10.1007/s00117-004-1149-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
392 Ishikawa T, Imai M, Ko M, Sato H, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm. Mol Clin Oncol 2017;7:61-6. [PMID: 28685077 DOI: 10.3892/mco.2017.1257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Jiang Y, Kimchi ET, Montero AJ, Staveley-O’Carroll KF, Ajani JA. Upper gastrointestinal tumors: current status and future perspectives. Expert Rev Anticancer Ther. 2008;8:975-991. [PMID: 18533807 DOI: 10.1586/14737140.8.6.975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
394 Chang YJ, Chen LJ, Chang YJ, Chen PD. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma. Eur J Surg Oncol 2020;46:1703-10. [PMID: 32475629 DOI: 10.1016/j.ejso.2020.04.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Spangenberg HC, Mohr L, Blum HE. [Regional therapy of liver tumors]. Internist (Berl). 2007;48:40-45. [PMID: 17160664 DOI: 10.1007/s00108-006-1771-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
396 Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158-171. [PMID: 16041205 DOI: 10.1097/01.sla.0000171032.99149.fe] [Cited by in Crossref: 503] [Cited by in F6Publishing: 434] [Article Influence: 31.4] [Reference Citation Analysis]
397 Raoul J. Natural History of Hepatocellular Carcinoma and Current Treatment Options. Seminars in Nuclear Medicine 2008;38:S13-8. [DOI: 10.1053/j.semnuclmed.2007.10.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
398 Herbold T, Wahba R, Bangard C, Demir M, Drebber U, Stippel DL. The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma—indication, technique and results. Langenbecks Arch Surg 2013;398:47-53. [DOI: 10.1007/s00423-012-1018-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
399 Taniguchi M, Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Fuki S, Sasase N, Matsuoka T, Kudo M. Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. World J Gastroenterol. 2008;14:1997-2002. [PMID: 18395898 DOI: 10.3748/wjg.14.1997] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
400 Hong K, Georgiades CS, Geschwind JF. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006;3:315-324. [PMID: 16757969 DOI: 10.1038/ncponc0512] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
401 Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2008;66:200-7. [DOI: 10.1016/j.critrevonc.2008.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
402 Min AL, Choi JY, Woo HY, Kim JD, Kwon JH, Bae SH, Yoon SK, Shin SH, Chung YJ, Jung CK. High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin Exp Metastasis. 2009;26:759-767. [PMID: 19533388 DOI: 10.1007/s10585-009-9275-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
403 Yin T, Li W, Zhao P, Wang Y, Zheng J. Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma. Clin Radiol 2017;72:136-40. [PMID: 27890422 DOI: 10.1016/j.crad.2016.10.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
404 Livraghi T. Radiofrequency ablation of hepatocellular carcinoma. Surg Oncol Clin N Am. 2011;20:281-299, viii. [PMID: 21377584 DOI: 10.1016/j.soc.2010.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
405 Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569-77; quiz 578. [PMID: 22158026 DOI: 10.1038/ajg.2011.425] [Cited by in Crossref: 406] [Cited by in F6Publishing: 370] [Article Influence: 40.6] [Reference Citation Analysis]
406 Craxì A, Cammà C. Prevention of hepatocellular carcinoma. Clin Liver Dis 2005;9:329-46, viii. [PMID: 15831277 DOI: 10.1016/j.cld.2004.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
407 Sharma P, Saini SD, Kuhn LB, Rubenstein JH, Pardi DS, Marrero JA, Schoenfeld PS. Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci. 2011;56:569-577. [PMID: 20978844 DOI: 10.1007/s10620-010-1453-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
408 Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hatanaka K, Ueda T, Hagiwara H, Kitai S, Ueshima K, Fukunaga T, Shiozaki H. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007;72 Suppl 1:111-6. [PMID: 18087191 DOI: 10.1159/000111716] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
409 Lencioni R, Della Pina C, Cioni D, Crocetti L. Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma. European Journal of Cancer Supplements 2008;6:1-8. [DOI: 10.1016/j.ejcsup.2008.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
410 Masaki T, Morishita A, Kurokohchi K, Kuriyama S. Multidisciplinary treatment of patients with hepatocellular carcinoma. Expert Review of Anticancer Therapy 2014;6:1377-84. [DOI: 10.1586/14737140.6.10.1377] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
411 Majno PE, Mentha G, Mazzaferro V. Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: Confirming the trial that will never be, and some comments on the indications for liver resection. Hepatology 2010;51:1116-8. [DOI: 10.1002/hep.23648] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
412 Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, Sacchetto P, Gandini G, Rizzetto M. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol. 2008;43:727-735. [PMID: 18569991 DOI: 10.1080/00365520701885481] [Cited by in Crossref: 181] [Cited by in F6Publishing: 160] [Article Influence: 13.9] [Reference Citation Analysis]
413 Ippolito D, Bonaffini PA, Capraro C, Leni D, Corso R, Sironi S. Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion. Abdom Imaging. 2013;38:502-510. [PMID: 22743839 DOI: 10.1007/s00261-012-9924-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
414 Stippel DL, Wahba R, Bruns CJ, Bunck A, Baues C, Persigehl T. [Image-guided, minimally invasive surgery and other local therapeutic procedures for primary liver tumors]. Chirurg 2018;89:872-9. [PMID: 30030546 DOI: 10.1007/s00104-018-0688-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
415 Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49:453-459. [PMID: 19065676 DOI: 10.1002/hep.22648] [Cited by in Crossref: 301] [Cited by in F6Publishing: 267] [Article Influence: 25.1] [Reference Citation Analysis]
416 Lai EC, Tang CN. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study. Int J Surg. 2013;11:77-80. [PMID: 23220487 DOI: 10.1016/j.ijsu.2012.11.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
417 Mazzoccoli G, Tarquini R, Valoriani A, Oben J, Vinciguerra M, Marra F. Management strategies for hepatocellular carcinoma: old certainties and new realities. Clin Exp Med 2016;16:243-56. [PMID: 26077653 DOI: 10.1007/s10238-015-0368-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
418 Palussière J, Marcet B, Descat E, Deschamps F, Rao P, Ravaud A, Brouste V, de Baère T. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol 2011;34:989-97. [PMID: 21127867 DOI: 10.1007/s00270-010-0048-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
419 Sim HW, Knox J, Dawson LA. An Update on Randomized Clinical Trials in Hepatocellular Carcinoma. Surg Oncol Clin N Am 2017;26:647-66. [PMID: 28923223 DOI: 10.1016/j.soc.2017.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
420 Shibata T, Shibata T, Maetani Y, Isoda H, Hiraoka M. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology. 2006;238:346-353. [PMID: 16373776 DOI: 10.1148/radiol.2381041848] [Cited by in Crossref: 105] [Cited by in F6Publishing: 76] [Article Influence: 7.0] [Reference Citation Analysis]
421 Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK; Interventional Oncology Task Force and Standards Division, Society of Interventional Radiology. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol 2009;20:3-8. [PMID: 18948025 DOI: 10.1016/j.jvir.2008.09.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
422 Mancuso A. Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol. 2013;5:302-310. [PMID: 23805354 DOI: 10.4254/wjh.v5.i6.302] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
423 Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G. Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol. 2015;21:12003-12021. [PMID: 26576088 DOI: 10.3748/wjg.v21.i42.12003] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
424 Maruyama H, Yoshikawa M, Yokosuka O. Current role of ultrasound for the management of hepatocellular carcinoma. World J Gastroenterol. 2008;14:1710-1719. [PMID: 18350602 DOI: 10.3748/wjg.14.1710] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
425 Toso C, Mentha G, Kneteman NM, Majno P. The place of downstaging for hepatocellular carcinoma. J Hepatol. 2010;52:930-936. [PMID: 20385428 DOI: 10.1016/j.jhep.2009.12.032] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 8.0] [Reference Citation Analysis]
426 Esneault S, Lafon C, Dillenseger JL. Liver vessels segmentation using a hybrid geometrical moments/graph cuts method. IEEE Trans Biomed Eng 2010;57:276-83. [PMID: 19783500 DOI: 10.1109/TBME.2009.2032161] [Cited by in Crossref: 51] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
427 Marrero JA, Pelletier S. Hepatocellular Carcinoma. Clinics in Liver Disease 2006;10:339-51. [DOI: 10.1016/j.cld.2006.05.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
428 Zhang L, Wang N, Shen Q, Cheng W, Qian GJ. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One. 2013;8:e76119. [PMID: 24146824 DOI: 10.1371/journal.pone.0076119] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
429 Choi D, Lim HK, Rhim H, Kim Y, Yoo BC, Paik SW, Joh J, Park CK. Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors. Ann Surg Oncol 2007;14:2319-29. [DOI: 10.1245/s10434-006-9220-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
430 Real M, Bianchi L, Vilana R, Burrel M, Rimola J. Tratamiento percutáneo e intraarterial del carcinoma hepatocelular. Radiología 2010;52:399-413. [DOI: 10.1016/j.rx.2010.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
431 Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249:20-25. [PMID: 19106671 DOI: 10.1097/sla.0b013e31818eec29] [Cited by in Crossref: 216] [Cited by in F6Publishing: 79] [Article Influence: 18.0] [Reference Citation Analysis]
432 Li D, Kang J, Golas BJ, Yeung VW, Madoff DC. Minimally invasive local therapies for liver cancer. Cancer Biol Med. 2014;11:217-236. [PMID: 25610708 DOI: 10.7497/j.issn.2095-3941.2014.04.001] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
433 Takeda A, Sanuki N, Eriguchi T, Kobayashi T, Iwabutchi S, Matsunaga K, Mizuno T, Yashiro K, Nisimura S, Kunieda E. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29:372-379. [PMID: 23927053 DOI: 10.1111/jgh.12350] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
434 Jeong H, Kim D, Kim DK, Chung IS, Bang YJ, Kim K, Kim M, Choi JW. Comparison of Respiratory Effects between Dexmedetomidine and Propofol Sedation for Ultrasound-Guided Radiofrequency Ablation of Hepatic Neoplasm: A Randomized Controlled Trial. J Clin Med 2021;10:3040. [PMID: 34300205 DOI: 10.3390/jcm10143040] [Reference Citation Analysis]
435 Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336-347. [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
436 Chen P, Chiu N, Su C, Huang Y, Hou M, Lin H, Wu J. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy. Journal of the Chinese Medical Association 2019;82:2-10. [DOI: 10.1097/jcma.0000000000000001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
437 Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, Zisimopoulos A, Andriotis E, Panagiotakos D, Fotopoulou A, Chrysohoou C, Bazinis A, Daskalopoulou D. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial. World J Gastroenterol. 2007;13:3164-3170. [PMID: 17589893 DOI: 10.3748/wjg.v13.i23.3164] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
438 Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M. Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 2015;7:21-7. [PMID: 26056497 DOI: 10.2147/HMER.S67940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
439 McLennan G, Bennett SL, Ju S, Babsky A, Bansal N, Shorten ML, Levitin S, Bonnac L, Panciewicz KW, Jayaram HN. Tumor response and apoptosis of N1-S1 rodent hepatomas in response to intra-arterial and intravenous benzamide riboside. Cardiovasc Intervent Radiol 2012;35:645-52. [PMID: 21431971 DOI: 10.1007/s00270-011-0140-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
440 Schullian P, Putzer D, Eberle G, Laimer G, Bale R. Simultaneous Stereotactic Radiofrequency Ablation of Multiple (≥ 4) Liver Tumors: Feasibility, Safety, and Efficacy. J Vasc Interv Radiol 2020;31:943-52. [PMID: 32414570 DOI: 10.1016/j.jvir.2019.12.794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
441 Wang JH, Tung HD, Chen TY, Hung CH, Chen CH, Changchien CS, Hu TH, Lee CM, Lu SN. Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxorubicin. Hepatol Int 2010;5:567-74. [PMID: 21442054 DOI: 10.1007/s12072-010-9215-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
442 Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before liver transplantation for HCC. Ann Surg Oncol. 2008;15:993-1000. [PMID: 18236111 DOI: 10.1245/s10434-007-9787-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 6.3] [Reference Citation Analysis]
443 Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, Marsh JW, Tsung A. Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB (Oxford) 2011;13:712-22. [PMID: 21929672 DOI: 10.1111/j.1477-2574.2011.00362.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
444 Qian GJ, Wang N, Shen Q, Sheng YH, Zhao JQ, Kuang M, Liu GJ, Wu MC. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies. Eur Radiol. 2012;22:1983-1990. [PMID: 22544225 DOI: 10.1007/s00330-012-2442-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 11.4] [Reference Citation Analysis]
445 Pan JJ, Javle M, Thinn MM, Hsueh CT, Hsueh CT. Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma. Hepat Med 2010;2:147-55. [PMID: 24367212 DOI: 10.2147/HMER.S7123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
446 Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol. 2008;190:W187-W195. [PMID: 18287411 DOI: 10.2214/ajr.07.2537] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
447 Izumi N, Asahina Y, Tsuchiya K, Kurosaki M, Nakanishi H, Kitamura T, Uchihara M, Miyake S. Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long-term survival. Hepatology Research 2007;37:S254-63. [DOI: 10.1111/j.1872-034x.2007.00193.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
448 Laeseke PF, Frey TM, Brace CL, Sampson LA, Winter TC, Ketzler JR, Lee FT. Multiple-Electrode Radiofrequency Ablation of Hepatic Malignancies: Initial Clinical Experience. American Journal of Roentgenology 2007;188:1485-94. [DOI: 10.2214/ajr.06.1004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
449 Hu XY, Li L, Wu HT, Liu Y, Wang BD, Tang Y. Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment. Pathol Res Pract 2018;214:1655-60. [PMID: 30153957 DOI: 10.1016/j.prp.2018.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
450 Park Y, Choi D, Rhim H, Kim YS, Lee JY, Chang I, Lim HK, Park CK. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance. Eur J Radiol 2010;75:391-6. [PMID: 19467813 DOI: 10.1016/j.ejrad.2009.04.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
451 Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89. [PMID: 18008357 DOI: 10.1002/hep.21933] [Cited by in Crossref: 705] [Cited by in F6Publishing: 623] [Article Influence: 54.2] [Reference Citation Analysis]
452 Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA, Pawlik TM. Hepatocellular carcinoma: From diagnosis to treatment. Surg Oncol. 2016;25:74-85. [PMID: 27312032 DOI: 10.1016/j.suronc.2016.03.002] [Cited by in Crossref: 165] [Cited by in F6Publishing: 149] [Article Influence: 33.0] [Reference Citation Analysis]
453 Kamarajah SK, Bundred JR, Littler P, Reeves H, Manas DM, White SA. Treatment strategies for early stage hepatocellular carcinoma: a systematic review and network meta-analysis of randomised clinical trials. HPB (Oxford) 2021;23:495-505. [PMID: 33309569 DOI: 10.1016/j.hpb.2020.10.031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
454 Forner A, Bruix J. Ablation for hepatocellular carcinoma: Is there need to have a winning technique? J Hepatol. 2010;52:310-312. [PMID: 20133005 DOI: 10.1016/j.jhep.2009.11.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
455 Liu Z, Zhou Y, Zhang P, Qin H. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech. 2010;20:130-140. [PMID: 20551807 DOI: 10.1097/sle.0b013e3181d823df] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
456 Wang Z, Yang G, Nie P, Fu J, Wang X, Liu D. Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS One 2013;8:e74327. [PMID: 23977399 DOI: 10.1371/journal.pone.0074327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
457 Buscarini E, Savoia A, Brambilla G, Menozzi F, Reduzzi L, Strobel D, Hänsler J, Buscarini L, Gaiti L, Zambelli A. Radiofrequency thermal ablation of liver tumors. Eur Radiol. 2005;15:884-894. [PMID: 15754165 DOI: 10.1007/s00330-005-2652-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
458 Sherman M. Primary Malignant Neoplasms of the Liver. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 681-703. [DOI: 10.1002/9781444341294.ch35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
459 Shibata T, Shibata T, Maetani Y, Kubo T, Itoh K, Togashi K, Hiraoka M. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol. 2004;15:1323-1327. [PMID: 15525754 DOI: 10.1097/01.rvi.0000132297.97113.c4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
460 Gustafson TP, Cao Q, Wang ST, Berezin MY. Design of irreversible optical nanothermometers for thermal ablations. Chem Commun (Camb) 2013;49:680-2. [PMID: 23223185 DOI: 10.1039/c2cc37271a] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
461 Weis S, Franke A, Berg T, Mössner J, Fleig WE, Schoppmeyer K. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst Rev 2015;1:CD006745. [PMID: 25620061 DOI: 10.1002/14651858.CD006745.pub3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
462 Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017;15:563-573. [PMID: 28476736 DOI: 10.6004/jnccn.2017.0059] [Cited by in Crossref: 155] [Cited by in F6Publishing: 135] [Article Influence: 38.8] [Reference Citation Analysis]
463 Sommer CM, Stampfl U, Kauczor HU, Pereira PL. [National S3 guidelines on hepatocellular carcinoma]. Radiologe 2014;54:642-53. [PMID: 25047521 DOI: 10.1007/s00117-014-2656-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
464 Ingle PV, Samsudin SZ, Chan PQ, Ng MK, Heng LX, Yap SC, Chai AS, Wong AS. Development and novel therapeutics in hepatocellular carcinoma: a review. Ther Clin Risk Manag. 2016;12:445-455. [PMID: 27042086 DOI: 10.2147/tcrm.s92377] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
465 Winter TC, Laeseke PF, Lee FT Jr. Focal tumor ablation: a new era in cancer therapy. Ultrasound Q 2006;22:195-217. [PMID: 16957613 DOI: 10.1097/01.ruq.0000232614.79547.b6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
466 Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, Lee KW, Joh JW. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005;39:247-252. [PMID: 15718869 DOI: 10.1097/01.mcg.0000152746.72149.31] [Cited by in Crossref: 181] [Cited by in F6Publishing: 160] [Article Influence: 11.3] [Reference Citation Analysis]
467 Frieser M, Strobel D, Schaber S, Wissniowski TT, Bernatik T, Adis S, Hahn EG, Hänsler JM. Getaktete Dreifachapplikation mit perfundierten Nadelapplikatoren bei Radiofrequenzablation: In-vitro-Versuch an der Rinderleber / Pulsed radiofrequency ablation using perfused needle applicators in an in vitro trial on bovine liver. Biomedizinische Technik/Biomedical Engineering 2010;55:101-7. [DOI: 10.1515/bmt.2010.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
468 Pan J, Chen S, Tian G, Jiang T. Preoperative Albumin-Bilirubin Grade With Prognostic Nutritional Index Predicts the Outcome of Patients With Early-Stage Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation. Front Med (Lausanne) 2020;7:584871. [PMID: 33240907 DOI: 10.3389/fmed.2020.584871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
469 Bruix J, Sherman M;  Practice Guidelines Committee;  American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. [PMID: 16250051 DOI: 10.1002/hep.20933] [Cited by in Crossref: 4104] [Cited by in F6Publishing: 3776] [Article Influence: 256.5] [Reference Citation Analysis]
470 Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceño J, Sastre J, Martí-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH]. Med Clin (Barc) 2016;146:511.e1-511.e22. [PMID: 26971984 DOI: 10.1016/j.medcli.2016.01.028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
471 Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol. 2008;17:23-31. [PMID: 17869095 DOI: 10.1016/j.suronc.2007.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
472 Park W, Chung YH, Kim JA, Jin YJ, Lee D, Shim JH, Lee D, Kim KM, Lim YS, Lee HC. Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns. Hepatol Res. 2013;43:1304-1312. [PMID: 23442052 DOI: 10.1111/hepr.12083] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
473 Hyoung Kim J, Nyun Kim P, Jin Won H, Moon Shin Y. Percutaneous Radiofrequency Ablation with Internally Cooled versus Internally Cooled Wet Electrodes for Small Subphrenic Hepatocellular Carcinomas. Journal of Vascular and Interventional Radiology 2013;24:351-6. [DOI: 10.1016/j.jvir.2012.11.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
474 Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, Lencioni R. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021;18:293-313. [PMID: 33510460 DOI: 10.1038/s41575-020-00395-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
475 Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, Zisimopoulos A, Andriotis E, Panagiotakos D, Fotopoulou A, Chrysohoou C, Bazinis A, Daskalopoulou D. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial. World J Gastroenterol. 2007;13:3164-3170. [PMID: 17589893 DOI: 10.3748/wjg.v13.i13.3164] [Reference Citation Analysis]
476 Sugo H, Ishizaki Y, Yoshimoto J, Imamura H, Kawasaki S. Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy. Ann Surg Oncol. 2012;19:2238-2245. [PMID: 22302262 DOI: 10.1245/s10434-012-2220-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
477 Vogl TJ, Farshid P, Naguib NN, Zangos S, Bodelle B, Paul J, Mbalisike EC, Beeres M, Nour-Eldin NE. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging. 2015;40:1829-1837. [PMID: 25601438 DOI: 10.1007/s00261-015-0355-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
478 Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol. 2006;17:1235-1249; quiz 1250. [PMID: 16923972 DOI: 10.1097/01.rvi.0000232177.57950.71] [Cited by in Crossref: 78] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
479 Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol. 2014;20:10223-10237. [PMID: 25132740 DOI: 10.3748/wjg.v20.i30.10223] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
480 Benoist S, Nordlinger B. Radiofrequency ablation in liver tumours. Annals of Oncology 2004;15:iv313-7. [DOI: 10.1093/annonc/mdh945] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
481 Rhim H, Kim Y, Choi D, Lim HK, Park K. Percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of 80 patients treated with two consecutive sessions. Eur Radiol 2008;18:1442-8. [DOI: 10.1007/s00330-008-0902-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
482 Vezali E, Aghemo A, Lampertico P, Colombo M. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis? Clin Res Hepatol Gastroenterol 2011;35:455-64. [PMID: 21435968 DOI: 10.1016/j.clinre.2011.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
483 Orlacchio A, Bazzocchi G, Pastorelli D, Bolacchi F, Angelico M, Almerighi C, Masala S, Simonetti G. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol. 2008;31:587-594. [PMID: 18236104 DOI: 10.1007/s00270-008-9293-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
484 Subramanian S, Pandey U, Chaudhari P, Tyagi M, Gupta S, Singh G, Dash A, Samuel G, Venkatesh M. Preliminary evaluation of indigenous 90 Y-labelled microspheres for therapy of hepatocellular carcinoma. Indian J Med Res 2016;143:S74-81. [PMID: 27748281 DOI: 10.4103/0971-5916.191786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
485 Sawada T, Kubota K, Kita J, Kato M, Shiraki T, Park K, Shimoda M. Clinical outcome of hepatectomy for hepatocellular carcinomas≤2 cm. World J Surg 2011;35:377-85. [PMID: 21042908 DOI: 10.1007/s00268-010-0851-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
486 Wiggermann P, Jung E, Stroszczynski C. Radiofrequenzablation – ist eine Technik am Ende? Radiologe 2012;52:9-14. [DOI: 10.1007/s00117-011-2206-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
487 Yu H, Burke CT. Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors. Semin Intervent Radiol. 2014;31:129-137. [PMID: 25071303 DOI: 10.1055/s-0034-1373788] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
488 Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol. 2009;20:S342-S347. [PMID: 19560023 DOI: 10.1016/j.jvir.2009.04.029] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
489 Shiozawa K, Watanabe M, Takayama R, Takahashi M, Wakui N, Iida K, Sumino Y. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. J Clin Ultrasound 2010;38:182-9. [PMID: 20232404 DOI: 10.1002/jcu.20685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
490 Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ohkawa A. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2012;82:e529-e535. [PMID: 22284041 DOI: 10.1016/j.ijrobp.2011.05.056] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
491 Knab LM, Salem R, Mahvi DM. Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 2013;50:146-79. [PMID: 23507316 DOI: 10.1067/j.cpsurg.2013.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
492 de Baère T, Palussière J, Aupérin A, Hakime A, Abdel-Rehim M, Kind M, Dromain C, Ravaud A, Tebboune N, Boige V. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587-596. [PMID: 16864679 DOI: 10.1148/radiol.2402050807] [Cited by in Crossref: 262] [Cited by in F6Publishing: 205] [Article Influence: 17.5] [Reference Citation Analysis]
493 Lencioni R, Della Pina C, Crocetti L, Cioni D. Percutaneous Ablation of Hepatocellular Carcinoma. In: Stroszczynski C, editor. Minimally Invasive Tumor Therapies. Berlin: Springer Berlin Heidelberg; 2006. pp. 91-105. [DOI: 10.1007/3-540-28137-1_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
494 Kim SW, Rhim H, Park M, Kim H, Kim YS, Choi D, Lim HK. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009;10:366-376. [PMID: 19568465 DOI: 10.3348/kjr.2009.10.4.366] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
495 Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Trétarre B. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008;98:505-9. [PMID: 18932235 DOI: 10.1002/jso.21159] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
496 Choi D, Lim HK, Kim MJ, Kim SH, Lee WJ, Kim SH, Lim JH, Paik SW, Koh KC, Yoo BC. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR Am J Roentgenol. 2004;183:1417-1424. [PMID: 15505314 DOI: 10.2214/ajr.183.5.1831417] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
497 Lencioni R, Crocetti L. Radiofrequency Ablation of Liver Cancer. Techniques in Vascular and Interventional Radiology 2007;10:38-46. [DOI: 10.1053/j.tvir.2007.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
498 Chiou SY, Liu JB, Needleman L. Current status of sonographically guided radiofrequency ablation techniques. J Ultrasound Med 2007;26:487-99. [PMID: 17384046 DOI: 10.7863/jum.2007.26.4.487] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
499 Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 2012;81:e189-93. [PMID: 21353417 DOI: 10.1016/j.ejrad.2011.01.122] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
500 Au JS, Frenette CT. Management of Hepatocellular Carcinoma: Current Status and Future Directions. Gut Liver. 2015;9:437-448. [PMID: 26087860 DOI: 10.5009/gnl15022] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
501 Weis S, Franke A, Berg T, Mössner J, Fleig WE, Schoppmeyer K. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst Rev 2015;1:CD006745. [PMID: 25620061 DOI: 10.1002/14651858.CD006745.pub3] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
502 Ashoori N, Bamberg F, Paprottka P, Rentsch M, Kolligs FT, Siegert S, Peporte A, Al-Tubaikh JA, D’Anastasi M, Hoffmann RT. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation. Digestion. 2012;86:338-348. [PMID: 23207185 DOI: 10.1159/000342813] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
503 Asahina Y, Nakanishi H, Izumi N. Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Dig Endosc. 2009;21:67-72. [PMID: 19691776 DOI: 10.1111/j.1443-1661.2009.00844.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
504 Osaki Y, Nishikawa H. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatol Res 2015;45:59-74. [PMID: 24965914 DOI: 10.1111/hepr.12378] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
505 Ye SL, Takayama T, Geschwind J, Marrero JA, Bronowicki JP. Current approaches to the treatment of early hepatocellular carcinoma. Oncologist. 2010;15 Suppl 4:34-41. [PMID: 21115579 DOI: 10.1634/theoncologist.2010-s4-34] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
506 Wong R, Frenette C, Gish R. Hepatocellular carcinoma: locoregional and targeted therapies. Gastroenterol Clin North Am. 2011;40:599-610. [PMID: 21893276 DOI: 10.1016/j.gtc.2011.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
507 Young JY, Rhee TK, Atassi B, Gates VL, Kulik L, Mulcahy MF, Larson AC, Ryu RK, Sato KT, Lewandowski RJ. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18:1375-1382. [PMID: 18003987 DOI: 10.1016/j.jvir.2007.07.016] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 6.2] [Reference Citation Analysis]
508 Laeseke PF, Sampson LA, Haemmerich D, Brace CL, Fine JP, Frey TM, Winter TC 3rd, Lee FT Jr. Multiple-electrode radiofrequency ablation creates confluent areas of necrosis: in vivo porcine liver results. Radiology 2006;241:116-24. [PMID: 16928978 DOI: 10.1148/radiol.2411051271] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
509 González Huezo MS, Sánchez Ávila JF. Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelular. Revista de Gastroenterología de México 2014;79:250-62. [DOI: 10.1016/j.rgmx.2014.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
510 Sangiovanni A, Colombo M. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2016;36 Suppl 1:124-129. [PMID: 26725909 DOI: 10.1111/liv.13028] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
511 Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005;11:6104-9. [PMID: 16273634 DOI: 10.3748/wjg.v11.i39.6104] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
512 Yu SCH, Leung TWT, Lau WY, Lee N, Hui EP, Yeo W, Lai PBS, Mok TSK. A Comparison of Three Transarterial Lipiodol-Based Formulations for Hepatocellular Carcinoma: In Vivo Biodistribution Study in Humans. Cardiovasc Intervent Radiol 2008;31:289-98. [DOI: 10.1007/s00270-007-9173-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
513 Lencioni R, Della Pina C, Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 2005;30:401-8. [DOI: 10.1007/s00261-004-0254-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
514 Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, Isaji S, Shiraki K, Fuke H, Uemoto S. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology. 2008;247:260-266. [PMID: 18305190 DOI: 10.1148/radiol.2471070818] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 10.2] [Reference Citation Analysis]
515 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 661] [Cited by in F6Publishing: 597] [Article Influence: 165.3] [Reference Citation Analysis]
516 Bonastre J, De Baère T, Elias D, Evrard S, Rouanet P, Bazin C, Giovannini M, Delpero JR, De Pouvourville G, Marchal F. Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroenterol Clin Biol 2007;31:828-35. [PMID: 18166861 DOI: 10.1016/s0399-8320(07)73973-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
517 Stolberg HO, Norman G, Trop I. Randomized Controlled Trials. American Journal of Roentgenology 2004;183:1539-44. [DOI: 10.2214/ajr.183.6.01831539] [Cited by in Crossref: 108] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
518 Lencioni R, Crocetti L. Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:181-194. [PMID: 22941021 DOI: 10.1007/978-3-642-16037-0_12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
519 Carrillo FJ, Mattos AA, Vianey AF, Vezozzo DC, Marinho F, Souto FJ, Cotrim HP, Coelho HS, Silva I, Garcia JH. Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma. Arq Gastroenterol. 2015;52 Suppl 1:2-14. [PMID: 26959803 DOI: 10.1590/s0004-28032015000500001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
520 Iizumi T, Okumura T, Sekino Y, Takahashi H, Tsai YL, Takizawa D, Ishida T, Hiroshima Y, Nakamura M, Shimizu S, Saito T, Numajiri H, Mizumoto M, Nakai K, Sakurai H. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma. J Radiat Res 2021;62:682-7. [PMID: 34036362 DOI: 10.1093/jrr/rrab040] [Reference Citation Analysis]
521 Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma. Gastroenterology 2005;129:122-30. [DOI: 10.1053/j.gastro.2005.04.009] [Cited by in Crossref: 623] [Cited by in F6Publishing: 521] [Article Influence: 38.9] [Reference Citation Analysis]
522 Di Costanzo GG, Tortora R, D’Adamo G, De Luca M, Lampasi F, Addario L, Galeota Lanza A, Picciotto FP, Tartaglione MT, Cordone G. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J Gastroenterol Hepatol. 2015;30:559-565. [PMID: 25251043 DOI: 10.1111/jgh.12791] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
523 Majno P, Giostra E, Morel P, Hadengue A, Mentha G. Management of hepatocellular carcinoma in the waiting list before liver transplantation. Journal of Hepatology 2005;42:S134-43. [DOI: 10.1016/j.jhep.2004.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
524 Francica G, Saviano A, De Sio I, De Matthaeis N, Brunello F, Cantamessa A, Giorgio A, Scognamiglio U, Fornari F, Giangregorio F, Piscaglia F, Gualandi S, Caturelli E, Roselli P, Rapaccini GL, Pompili M. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Dig Liver Dis. 2013;45:336-341. [PMID: 23245589 DOI: 10.1016/j.dld.2012.10.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
525 Legoux J, Bedenne L, Seitz J, Pezet D, Rougier P, Bouché O, Barbare J, André T, Malka D, Cadiot G, Ruskoné-foumestraux A, Landi B, Peiffert D, Ducreux M, Louvet C, Dorval E. Quels changements dans le Thésaurus National de Cancérologie Digestive en 2005 ? Gastroentérologie Clinique et Biologique 2006;30:1191-5. [DOI: 10.1016/s0399-8320(06)73510-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
526 Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009;19:2630-2640. [PMID: 19557416 DOI: 10.1007/s00330-009-1463-x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 90] [Article Influence: 9.8] [Reference Citation Analysis]
527 Del Pozo AC, López P. Management of hepatocellular carcinoma. Clin Liver Dis. 2007;11:305-321. [PMID: 17606209 DOI: 10.1016/j.cld.2007.04.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
528 Lee JM, Han JK, Kim SH, Lee JY, Shin KS, Han CJ, Lee MW, Choi JI, Choi BI. Optimization of wet radiofrequency ablation using a perfused-cooled electrode: a comparative study in ex vivo bovine livers. Korean J Radiol 2004;5:250-7. [PMID: 15637475 DOI: 10.3348/kjr.2004.5.4.250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
529 Li K, Wang HT, He YK, Guo T. New idea for treatment strategies for Barcelona Clinic Liver Cancer stages based on a network meta-analysis. Medicine (Baltimore) 2017;96:e6950. [PMID: 28514316 DOI: 10.1097/MD.0000000000006950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
530 Schwarz RE, Smith DD. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg. 2008;195:829-836. [PMID: 18436176 DOI: 10.1016/j.amjsurg.2007.10.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
531 Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon. 2005;3:210-215. [PMID: 16076007 DOI: 10.1016/s1479-666x(05)80043-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
532 Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, Kim PN. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol. 2011;18:1624-1629. [PMID: 21445671 DOI: 10.1245/s10434-011-1673-8] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 10.0] [Reference Citation Analysis]
533 Huo T, Lee S. Management of inoperable hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19:S272-8. [DOI: 10.1111/j.1440-1746.2004.03686.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
534 Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, Dai WC, Chan AC, Chan SC, Yau TC, Poon RT, Lo CM. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB (Oxford) 2013;15:567-73. [PMID: 23458602 DOI: 10.1111/hpb.12025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
535 Kawamura R, Seki T, Umehara H, Ikeda K, Inokuchi R, Asayama T, Yamaguchi T, Takahashi Y, Sakao M, Lencioni R. Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation. Cardiovasc Intervent Radiol. 2012;35:325-333. [PMID: 21607824 DOI: 10.1007/s00270-011-0184-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
536 Kim JH, Yim HJ, Lee KG, Kim SY, Jung ES, Jung YK, Seo YS, Yeon JE, Lee HS, Um SH. Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study. Hepatol Int. 2011;Epub ahead of print. [PMID: 21728030 DOI: 10.1007/s12072-011-9290-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
537 Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol. 2008;190:1544-1551. [PMID: 18492905 DOI: 10.2214/ajr.07.2798] [Cited by in Crossref: 65] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
538 Ramacciato G, Mercantini P, Petrucciani N, Ravaioli M, Cucchetti A, Del Gaudio M, Cescon M, Ziparo V, Pinna AD. Does Surgical Resection Have a Role in the Treatment of Large or Multinodular Hepatocellular Carcinoma? The American Surgeon 2010;76:1189-97. [DOI: 10.1177/000313481007601116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
539 Wang J, Changchien C, Hu T, Lee C, Kee K, Lin C, Chen C, Chen T, Huang Y, Lu S. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients. European Journal of Cancer 2008;44:1000-6. [DOI: 10.1016/j.ejca.2008.02.018] [Cited by in Crossref: 142] [Cited by in F6Publishing: 143] [Article Influence: 10.9] [Reference Citation Analysis]
540 Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol. 2015;7:2274-2291. [PMID: 26380652 DOI: 10.4254/wjh.v7.i20.2274] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
541 Lee ES, Lee JM, Kim KW, Lee IJ, Han JK, Choi BI. Evaluation of the in vivo efficiency and safety of hepatic radiofrequency ablation using a 15-G Octopus® in pig liver. Korean J Radiol 2013;14:194-201. [PMID: 23482995 DOI: 10.3348/kjr.2013.14.2.194] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
542 Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, Abei M, Shoda J, Tohno E, Minami M. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys. 2008;71:462-467. [PMID: 18243571 DOI: 10.1016/j.ijrobp.2007.09.056] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
543 Palesty JA, Al-Kasspooles M, Gibbs JF. Patient selection for surgical management of primary and metastatic liver cancers: current perspectives. Semin Intervent Radiol 2006;23:13-20. [PMID: 21326716 DOI: 10.1055/s-2006-939837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
544 Cheung TT, Ng KK, Poon RT, Fan ST. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:655-660. [PMID: 19370304 DOI: 10.1007/s00534-009-0103-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
545 Tranberg KG. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol. 2004;18:125-145. [PMID: 15123088 DOI: 10.1016/j.bpg.2003.08.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
546 Lencioni R, Crocetti L, Cioni D, Della Pina C, Bartolozzi C. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol. 2004;39:689-697. [PMID: 15486530 DOI: 10.1097/00004424-200411000-00007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 93] [Article Influence: 7.8] [Reference Citation Analysis]
547 Kelsey CR, Schefter T, Nash SR, Russ P, Barón AE, Zeng C, Gaspar LE. Retrospective Clinicopathologic Correlation of Gross Tumor Size of Hepatocellular Carcinoma: Implications for Stereotactic Body Radiotherapy. American Journal of Clinical Oncology 2005;28:576-80. [DOI: 10.1097/01.coc.0000184657.65679.6f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
548 Chang IS, Rhim H, Kim SH, Kim YS, Choi D, Park Y, Lim HK. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. AJR Am J Roentgenol. 2010;195:1131-1136. [PMID: 20966318 DOI: 10.2214/ajr.09.3946] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
549 Nishikawa H, Osaki Y, Iguchi E, Takeda H, Matsuda F, Nakajima J, Sakamoto A, Hatamaru K, Saito S, Nasu A, Kita R, Kimura T. Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol 2013;48:951-65. [PMID: 23065022 DOI: 10.1007/s00535-012-0690-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
550 Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg. 2005;92:1393-1398. [PMID: 16044409 DOI: 10.1002/bjs.5102] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
551 Kalra N, Gupta P, Chawla Y, Khandelwal N. Locoregional treatment for hepatocellular carcinoma: The best is yet to come. World J Radiol. 2015;7:306-318. [PMID: 26516427 DOI: 10.4329/wjr.v7.i10.306] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
552 Nault J, Sutter O, Nahon P, Ganne-carrié N, Séror O. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. Journal of Hepatology 2018;68:783-97. [DOI: 10.1016/j.jhep.2017.10.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 33.0] [Reference Citation Analysis]
553 Colombo M, Raoul J, Lencioni R, Galle PR, Zucman-rossi J, Bañares R, Seehofer D, Neuhaus P, Johnson P. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. European Journal of Gastroenterology & Hepatology 2013;25:639-51. [DOI: 10.1097/meg.0b013e32835e33bb] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
554 Subramanian S, Vimalnath KV, Dash A. Preparation and preliminary in vivo evaluation of 166 Ho-labeled microspheres for possible use in radioembolic therapy of liver cancer. J Labelled Comp Radiopharm 2018;61:509-14. [PMID: 29462501 DOI: 10.1002/jlcr.3616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
555 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Reference Citation Analysis]
556 Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 2004;10:S91-7. [PMID: 14762847 DOI: 10.1002/lt.20043] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
557 Bholee AK, Peng K, Zhou Z, Chen J, Xu L, Zhang Y, Chen M. Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study. Clin Transl Oncol. 2017;19:844-852. [PMID: 28070766 DOI: 10.1007/s12094-016-1611-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
558 Facciuto ME, Singh MK, Rochon C, Sharma J, Gimenez C, Katta U, Moorthy CR, Bentley-Hibbert S, Rodriguez-Davalos M, Wolf DC. Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: evaluation of radiological and pathological response. J Surg Oncol. 2012;105:692-698. [PMID: 21960321 DOI: 10.1002/jso.22104] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
559 Kuo YH, Lu SN, Chen CL, Cheng YF, Lin CY, Hung CH, Chen CH, Changchien CS, Hsu HC, Hu TH. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer. 2010;46:744-751. [PMID: 20060710 DOI: 10.1016/j.ejca.2009.12.018] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
560 Tong J, Liu P, Ji M, Wang Y, Xue Q, Yang JJ, Zhou CM. Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients. Clin Med Insights Oncol 2021;15:11795549211000017. [PMID: 33854400 DOI: 10.1177/11795549211000017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 Shiina S. Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009;44:122-31. [DOI: 10.1007/s00535-008-2263-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
562 Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T, Arimoto A, Osaki Y. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 2011;11:143. [PMID: 22204311 DOI: 10.1186/1471-230X-11-143] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 4.9] [Reference Citation Analysis]
563 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58. [PMID: 22190656 DOI: 10.1148/radiol.11110144] [Cited by in Crossref: 211] [Cited by in F6Publishing: 194] [Article Influence: 23.4] [Reference Citation Analysis]
564 Moumouh A, Hannequin J, Chagneau C, Rayeh F, Jeanny A, Weber-Holtzscherer A, Tasu JP. A tamponade leading to death after radiofrequency ablation of hepatocellular carcinoma. Eur Radiol. 2005;15:234-237. [PMID: 15503044 DOI: 10.1007/s00330-004-2485-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
565 Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-594. [PMID: 18620773 DOI: 10.1016/j.jhep.2008.05.018] [Cited by in Crossref: 124] [Cited by in F6Publishing: 116] [Article Influence: 9.5] [Reference Citation Analysis]
566 Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Helmberger T, Gillams AR, Frilling A, Ambrogi M. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621-628. [PMID: 18565793 DOI: 10.1016/s1470-2045(08)70155-4] [Cited by in Crossref: 356] [Cited by in F6Publishing: 94] [Article Influence: 27.4] [Reference Citation Analysis]
567 Callstrom MR, Charboneau JW. Technologies for ablation of hepatocellular carcinoma. Gastroenterology. 2008;134:1831-1835. [PMID: 18486619 DOI: 10.1053/j.gastro.2008.05.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
568 Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, Della Pina C, Bargellini I, Cioni D, Oliveri F, De Simone P, Bartolozzi C, Brunetto M, Filipponi F. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study. Journal of Hepatology 2008;49:217-22. [DOI: 10.1016/j.jhep.2008.03.021] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
569 Groeschl RT, Gamblin TC, Turaga KK. Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint. Ann Surg Oncol. 2013;20:3591-3595. [PMID: 23720072 DOI: 10.1245/s10434-013-3031-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
570 Viveiros P, Riaz A, Lewandowski RJ, Mahalingam D. Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC). Cancers (Basel) 2019;11:E1085. [PMID: 31370248 DOI: 10.3390/cancers11081085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
571 Seror O. Percutaneous hepatic ablation: What needs to be known in 2014. Diagnostic and Interventional Imaging 2014;95:665-75. [DOI: 10.1016/j.diii.2014.04.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
572 Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. Clin Radiol. 2005;60:1018-1025. [PMID: 16124984 DOI: 10.1016/j.crad.2005.04.009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
573 Lermite E, Lebigot J, Oberti F, Pessaux P, Aube C, Cales P, Arnaud J. Radiofrequency thermal ablation of liver carcinoma. Gastroentérologie Clinique et Biologique 2006;30:130-5. [DOI: 10.1016/s0399-8320(06)73128-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
574 Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009;6:159-69. [DOI: 10.1038/ncpgasthep1357] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
575 Hernández-Guerra M, Hernández-Camba A, Turnes J, Ramos LM, Arranz L, Mera J, Crespo J, Quintero E. Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival. United European Gastroenterol J 2015;3:284-93. [PMID: 26279838 DOI: 10.1177/2050640615575971] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
576 Elvin A, Skogseid B, Hellman P. Radiofrequency ablation of neuroendocrine liver metastases. Abdom Imaging. 2005;30:427-434. [PMID: 15791486 DOI: 10.1007/s00261-004-0257-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
577 Pompili M, Riccardi L, Covino M, Barbaro B, Di Stasi C, Orefice R, Gasbarrini G, Rapaccini GL. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver Int. 2005;25:954-961. [PMID: 16162152 DOI: 10.1111/j.1478-3231.2005.01135.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
578 Mironov O, Jaberi A, Kachura JR. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population. Journal of Vascular and Interventional Radiology 2017;28:325-33. [DOI: 10.1016/j.jvir.2016.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]